Stockwinners Market Radar for October 01, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

21:08 EDT Oracle to invest over $6.5B in AI, cloud servies in Malaysia - The company stated: "To meet the rapidly growing demand for its artificial intelligence and cloud services in Malaysia, Oracle (ORCL) announced plans to invest more than $6.5B to open a public cloud region in the country. The upcoming cloud region will enable Oracle customers and partners in Malaysia to leverage AI infrastructure and services and migrate mission-critical workloads to Oracle Cloud Infrastructure. The planned public cloud region will help organizations in Malaysia modernize their applications, migrate all types of workloads to the cloud, and innovate with data, analytics, and AI. Customers can have access to OCI Generative AI Agents with retrieval-augmented generation capabilities; accelerated computing and generative AI services to help keep sovereign AI models within country borders; and OCI Supercluster, the largest AI supercomputer in the cloud-orderable with up to 131,072 NVIDIA (NVDA) Blackwell GPUs with NVIDIA ConnectX-7 NICs for RoCEv2 networking or NVIDIA GB200 NVL72 rack solutions using liquid cooling and NVIDIA Quantum-2 InfiniBand networking. In addition, 150+ services, including Oracle Autonomous Database, HeatWave MySQL Database Service, Oracle Cloud VMware Solution, OCI Kubernetes Engine, and Oracle Fusion Cloud Applications Suite will also be available, offering customers infrastructure, platform, or SaaS services."

20:08 EDT Cathie Wood's ARK Investment buys 44K shares of Blade Air Mobility today

19:50 EDT Sobr Safe Inc trading halted, news pending

19:48 EDT Topline Capital buys $2.4M in Green Dot common stock - In a regulatory filing, Green Dot disclosed that major holder Topline Capital bought 199K shares of common stock on September 23rd in a total transaction size of $2.4M. Shares of Green Dot were up 1.7% afterhours at $11.21.

17:38 EDT Tailwater announces sale of Tall Oak Midstream Operating to Summit Midstream - Tailwater Capital announced that it has entered into definitive agreements with Summit Midstream Corporation and its wholly owned subsidiary Summit Midstream Partners, whereby Summit will acquire Tall Oak Midstream Operating, and its subsidiaries for a total consideration of approximately $450M. Consideration is comprised of $155Min cash, approximately 7.5 million shares of a combination of SMC Class B common stock and common units of the Partnership, representing approximately 40% ownership in the pro forma company, and up to $25M contingent consideration in cash over certain measurement periods through March 31, 2026. The transaction is expected to close in the Q4, subject to customary closing conditions, shareholder approval and regulatory approvals. Upon closing, four directors appointed by Tailwater Capital will serve on the pro forma Summit Board. TPH&Co., the energy business of Perella Weinberg Partners, served as exclusive financial advisor to Tailwater Capital. Kirkland & Ellis served as legal advisor to Tall Oak Midstream and Tailwater Capital. Guggenheim Securities, served as financial advisor and Locke Lord served as legal advisor to Summit.

17:35 EDT Lamb Weston implements restructuring plan, curtailment of production lines - The company states: "The Company is implementing a restructuring plan that is designed to drive operational and cost efficiencies and improve cash flows, while positioning the Company to continue to make strategic investments to drive long-term value for its stakeholders. The Restructuring Plan includes: The permanent closure of the Company's manufacturing facility in Connell, Washington, effective October 1, 2024; The temporary curtailment of certain production lines and schedules across its manufacturing network in North America; A reduction in operating expenses, including headcount reductions approximating 4% of the Company's global workforce and the elimination of certain unfilled job positions; and A $100 million reduction in fiscal 2025 capital expenditures to $750 million from the Company's previous estimate of $850 million. The Company estimates that the Restructuring Plan will generate approximately $55 million in pre-tax cost savings and a reduction in working capital in fiscal 2025. The estimated savings and improvements in cash flow have been reflected in the Company's updated fiscal 2025 financial targets. In connection with the Restructuring Plan, the Company expects to record total estimated pre-tax charges of $200 million to $250 million, of which the Company estimates that approximately 80 percent will be cash and 20 percent will be non-cash. The charges primarily relate to the cost of contracted raw potatoes that will not be used due to production line curtailments, accelerating depreciation of assets, the write-down of inventory and long-lived assets, employee severance and other one-time termination benefits, and other costs. The Company expects to record most of the pre-tax charges in the second quarter of fiscal 2025, with the remainder expected to be recorded during the second half of fiscal 2025."

17:22 EDT Nike extending decline to 6% as company withdraws guidance

17:02 EDT CAE awarded contract from SkyAlyne - CAE announced that it has signed a 25-year sub-contract valued at approximately $1.7B from SkyAlyne, a joint venture between CAE and KF Aerospace, to provide the Royal Canadian Air Force, or RCAF, with modern, state-of-the-art pilot training. As a major subcontractor to the Future Air Crew Training, or FAcT, program, CAE will deliver over the course of the contract term comprehensive aircrew training including live flying, simulation, and ground school training. This will extend CAE's long-standing presence at 15 Wing Moose Jaw where CAE currently operates the NATO Flying Training in Canada, or NFTC, program. As part of this sub-contract, CAE will initially develop and deliver a range of simulators and training devices to be installed in Moose Jaw, Saskatchewan and at Southport, Manitoba for the various aircraft fleets being procured for the RCAF under the FAcT program. These training devices are expected to be delivered over the next 5 years. In addition to this initial approximately $1.7B sub-contract, CAE is also expected to sign a follow-on order in the near term involving sustainment-related in-service support services.

16:42 EDT Kimco Realty acquires Waterford Lakes Town Center in Orlando for $322M - Kimco Realty announced the acquisition of Waterford Lakes Town Center, a 976,000-square-foot signature asset spanning 79 acres in Orlando, Florida for $322M, including the assumption of a $164M mortgage. The property, which is approximately 99% occupied, features a high-quality tenant mix that combines lifestyle and entertainment uses with essential goods and services. Located in Orlando's upscale West University submarket, Waterford Lakes Town Center sits three miles south of the University of Central Florida, which is the largest university by enrollment in Florida with approximately 70,000 students. The shopping center serves an extensive trade area, with an estimated population of over 228,000 and an average household income of $111,000 within a five-mile radius, and situated in one of the fastest-growing metro areas in the U.S. With the acquisition of Waterford Lakes, Kimco's total acquisition activity, including structured investments, has surpassed $560M for the year. Accordingly, the company raises total acquisitions & structured investments combined to $565M-$625M or 8.0%-8.25% to $300M-$350M or 7.0% to 8.0%. The company will provide a full update to its 2024 guidance and related assumptions when it reports third-quarter earnings on October 31.

16:35 EDT Nike reports Q1 inventories down 5% at $8.3B - Reports Q1 gross margin up 120bps at 45.4%. Reports Q1 NIKE Brand Revenues $11.1B, down 10% on a reported basis and down 9% on a currency-neutral basis, "due to declines across all geographies". NIKE Q1 Direct revenues were $4.7B , down 13% on a reported basis and down 12% on a currency-neutral basis, primarily due to a 20% decrease in NIKE Brand Digital, partially offset by a 1% increase in NIKE-owned stores. Wholesale revenues were $6.4B, down 8% on a reported basis and down 7% on a currency-neutral basis.

16:31 EDT AeroVironment successfully flight tests new solar-powered aircraft - The company states: "AeroVironment flight-tested an upgraded Sunglider, enhancing its High-Altitude Platform-Station capabilities for commercial and government markets. The result is Horus A, the new version of Sunglider for government applications. Horus A is a solar-powered UAS capable of carrying up to 150 lb of payload with 1.5 kW of available power, offering industry-leading stratospheric performance. Horus A features enhancements in all areas of the aircraft design, avionics, and offers unique features such as additional autonomy to increase mission flexibility and multiple redundant systems for mission assurance. Horus A received airworthiness approval from the U.S. Army and an FAA Special Airworthiness Certificate to allow flight testing in the national airspace. These enhancements flow back into the continued development of Sunglider with SoftBank as both companies strive to deliver unrivaled payload capacity and persistence to unlock the full potential of both stratospheric flight and the latest, most capable payloads. "

16:30 EDT LPL Financial trading resumes

16:20 EDT Mondelez announces investment in Urban Legend - Mondelez announced that its corporate venture capital arm, SnackFutures Ventures, has taken a minority stake in Urban Legend, a fresh doughnut and pastry business in the United Kingdom. All Urban Legend varieties - including those with creamy fillings, icings and frostings - are 200 calories or less.

16:18 EDT Service announces leadership promotions among executive officers - Service Corporation International announced leadership promotions among its executive officers that were made and approved by the SCI Board of Directors in continuation of the Board's focus on succession planning to support SCI's long-term growth. Steven A. Tidwell, SCI's Senior Vice President of Sales and Marketing, informed the Company of his intent to step down from his role as an executive officer and assume a new role as Special Advisor to the CEO, effective October 1, 2024. Sumner J. Waring, III, who currently serves as COO, has been promoted to President. In addition to indirectly leading SCI's operations, Waring will assume Tidwell's sales and marketing responsibilities. Waring's successful record of leadership in his numerous operations roles and commitment to the profession as a fifth-generation funeral director make him uniquely qualified to assume the role of President. John Faulk, who currently serves as Senior Vice President of Revenue and Business Development, has been promoted to Senior Vice President and CFO With his strategic acumen, institutional knowledge and broad business experience, Faulk is the ideal leader to support SCI's funeral and cemetery operations. Eric D. Tanzberger, who currently serves as Senior Vice President and CFO, has been promoted to Executive Vice President and CFO, and will oversee business development, including mergers and acquisitions, construction and real estate, as well as pricing and revenue development, in addition to his current responsibilities. His financial expertise and proven leadership will be instrumental in working with these teams to drive SCI's future growth. Aaron G. Foley, who currently serves as Vice President and Treasurer, has been promoted to Senior Vice President and Treasurer, and will oversee accounting, tax, and risk assurance and advisory services, in addition to his current responsibilities. His 16 years of financial, accounting and management experience with SCI will serve him well in his new role. In their new roles, Messrs. Waring and Tanzberger will continue to report to Ryan, Faulk will report to Waring and Mr. Foley will continue to report to Tanzberger.

16:17 EDT Nike says Investor Day is being postponed

16:13 EDT LifeVantage announces update to evolve compensation plan with new sharing bonus - LifeVantage announced an enhancement to its Evolve Compensation Plan, offering greater simplicity and earning potential for independent LifeVantage Consultants. Plan enhancements are set to go live November 1 in the U.S., Japan, Australia, New Zealand, Canada, Mexico, and European markets. "When we modernized our compensation plan and launched Evolve in March 2023, it came with the commitment to continuously simplify and enhance the way Consultants earn money at LifeVantage," said Steve Fife, President and CEO. "The latest enhancements deliver on that promise while further cementing LifeVantage as a leader in Consultant compensation. Sharing LifeVantage and our unique approach to health and wellness is simple, exciting, and now, even more rewarding, especially as you are just getting started."..."There has never been a better time to be a LifeVantage Consultant," said Fife. "Our upcoming launch of an innovative weight management system that naturally activates GLP-1 combined with the enhancements to our Evolve Compensation Plan create compelling growth opportunities for entrepreneurs."

16:11 EDT Teladoc reports Chief Operating Officer Michael Waters resigned - In a regulatory filing, Teladoc Health reported that on September 27, Michael Waters, Chief Operating Officer of the company, resigned with good reason under his executive employment agreement with the company in connection with a change in the company's executive reporting structure. "Mr. Waters' resignation is effective on the close of business on December 31, 2024. The Company thanks Mr. Waters for his service," the filing stated. Reference Link

16:09 EDT 10x Genomics announces plan to deliver single cell analysis - At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy, 10x Genomics shared new details about its upcoming product roadmap and its ongoing strategy to democratize access to single cell analysis. During its Foundational Sponsor talk in the Sept. 29 Technology Showcase, 10x Genomics announced an imminent plan to deliver "single cell for a single cent." Through a series of new products and configurations expected to launch this quarter, 10x Genomics intends to deliver mega-scale single cell analysis at a cost as low as 1c per cell. 10x Genomics believes its upcoming launches, which enable 2.5 million cells per run and 5 million cells per kit, will be the most cost effective single cell products available for CRISPR screens, cell atlassing projects and other high-throughput applications. In addition to new solutions for mega-scale applications, 10x Genomics' planned launches this quarter will feature cost effective products to increase access to and adoption of single cell in additional applications and use cases. These new offerings are expected to enable researchers to perform single cell experiments, even at a small scale, for approximately $560 per sample.

16:08 EDT Diamondback Energy sees Q3 oil production 319-321 mbo/d - Sees Q3 cash capital expenditures $675M-$700M. This guidance has been updated to give effect to the Endeavor Energy Resources merger, which was completed on September 10.

16:07 EDT ICF International awarded BPA by EPA Office of Water - The U.S. Environmental Protection Agency, or EPA, Office of Water, or OW, recently awarded a single-award blanket purchase agreement, or BPA, to global consulting and technology services provider ICF to provide environmental, economic, regulatory and evaluation services to the agency's critical water programs. The recompete BPA has a ceiling value of $75M and a term of five years, including a one-year base and four one-year option periods. ICF's economists and environmental assessors will study and quantify the environmental and health effects, benefits, costs and economic impacts of OW's regulatory actions. In addition, the company will leverage cloud computing and data analytics to perform analyses more efficiently. Together this work will help reduce pollutants in U.S. waters, improve drinking water quality, reduce exposure to toxics and emerging contaminants in water, and more.

16:06 EDT RGP unveils new brand identity, brand architecture - RGP revealed a new brand identity and brand architecture to create clarity around the company's enhanced value proposition. The company has made organizational shifts to distinctly position RGP as a parent company with three principal business segments: On-Demand by RGP, Veracity by RGP and Countsy by RGP. These updates align with the operational changes that RGP has made to evolve its business strategy starting in fiscal year 2025. "The changes we've made are enabling us to unlock the value of our diversified capabilities, better situating us to support companies with their workforce and transformation strategies regardless of their corporate lifecycle or unique circumstances," said Kate Duchene, Chief Executive Officer at RGP. "Our new organizational structure and intentional brand architecture create a unified ecosystem that better showcases the full value that RGP brings to our stakeholders. This evolution ensures that RGP will be well-positioned over the long-term to execute and succeed regardless of the macro environment by leveraging our differentiated and deep experience across a diverse set of industries." RGP expects the changes it has made to expand the company's addressable market through an evolved service offering catalog, while positioning the firm to drive cross-sell growth throughout its extensive enterprise client base that includes over 1,700 active MSAs globally.

16:05 EDT Bank OZK raises quarterly cash dividend 2.5% to 41c per share - Bank OZK announced its Board of Directors declared a quarterly cash dividend on the Bank's common stock of 41c per share, up 1c 1, or 2.5% from the prior quarter. The common stock dividend is payable on October 18 to shareholders of record as of October 11 . Bank OZK has increased its quarterly cash dividend on its common stock in each of the last fifty-seven quarters.

16:01 EDT LPL Financial board terminates CEO Dan Arnold for workplace violations - LPL Financial Holdings Inc. announced that the Board of Directors has terminated the company's President and Chief Executive Officer, Dan H. Arnold, effective immediately, for violating LPL's commitment to a respectful workplace. He has also resigned from the Board. The Board has appointed Rich Steinmeier, currently the company's Managing Director, Chief Growth Officer, as Interim CEO, also effective immediately. The Board terminated Mr. Arnold for cause on the recommendation of a special committee of Directors in the course of an investigation by an outside law firm, which found he made statements to employees that violated LPL's Code of Conduct. "LPL's Code of Conduct requires every employee, no matter their title, to foster a supportive and professional workplace and show respect to each other, our stakeholders and the broader community," said James Putnam, Chair of the Board of Directors. "Mr. Arnold failed to meet these obligations."

15:48 EDT ISS recommends Territorial Bancorp shareholders vote against Hope Bancorp merger - Blue Hill Advisors and former Hawaii banking executive Allan Landon announced that Institutional Shareholder Services, or ISS, an independent proxy advisory firm, has recommended that shareholders of Territorial Bancorp (TBNK) vote against the proposed merger between Territorial and Hope Bancorp (HOPE) at the company's special meeting of stockholders on October 10. In its report, ISS concluded that Hope's takeover of Territorial is not in the best interest of the Company's shareholders: "Given the lack of a robust sales process, the fact that the merger agreement restrictions accepted by the board limit its ability to engage with a competing bidder, and the improved outlook for financial institutions, the proposed merger with HOPE does not appear to maximize value for shareholders."

15:33 EDT 23andMe CEO says not open to considering 'third party takeover proposals' - Ms. Wojcicki has updated her prior statement about whether Ms. Wojcicki would be open to considering third party takeover proposals for the 23andMe: "In response to a request from the then-current Special Committee of the Board, I stated that I would consider third party takeover proposals for 23andMe. Whether I would ultimately accept such a proposal remained within my discretion. In the interim period, based on subsequent developments, it has become even clearer to me that the best path forward for 23andMe is for me to take the company private. Accordingly, in order to update my prior statement and avoid any confusion in the market, I am no longer open to considering third party takeover proposals for 23andMe. I remain committed to completing an acquisition of 23andMe. Towards that end, the Issuer is working diligently to repopulate the Board of Directors so that any proposals to acquire 23andMe can be properly considered. Importantly, I remain committed to our customers' privacy and pledge to maintain23andMe current privacy policy in effect for the foreseeable future, including following completion of the acquisition I am currently pursuing." This information is from a company 8K regulatory filing... Reference Link

15:17 EDT Chevron aims to increase Gulf of Mexico output to 300K net BOE per day by 2026 - Chevron said it is aiming to increase its U.S. Gulf of Mexico production to 300,000 net barrels of oil-equivalent per day by 2026, and two projects that recently started operations could help it get there. In September, Chevron announced that it had begun water injection at its St. Malo offshore field. This is Chevron's first waterflood project in the deepwater Wilcox trend. The project, which was completed under budget, is expected to recover approximately 175 gross BOE. That's in addition to the almost 400 million gross BOE produced to date from the Jack and St. Malo fields. Less than 100 miles away, Chevron's Tahiti facility-which has produced more than 500 million gross BOE since 2009-has also expanded waterflood operations to boost production.

14:24 EDT Humana falls after releasing 2025 Medicare Advantage offerings - Shares of Humana (HUM) are moving lower after the company announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025. "Based on member feedback, Humana is including coverage for new glasses every year in every plan with a vision benefit. Humana also is offering plans with comprehensive dental coverage that includes deep cleanings, fillings and crowns in nearly every county it serves," the company said in a statement. Humana has a total of 793 individual Medicare Advantage plans throughout the country for 2025. Members with Part D coverage will now have a $2,000 cap on out-of-pocket drug costs, and they will no longer have a coverage gap phase. In 2025, Humana will have Medicare Advantage plan offerings in 48 states, plus Washington, D.C., and Puerto Rico, covering 89% of U.S. counties. Shares of Humana are down 6% to $297.89 in afternoon trading. Shares of Alignment Healthcare (ALHC), which also released its 2025 Medicare Advantage offerings this morning, are down 17%, or $1.99, to $9.83.

12:33 EDT American Honda reports September sales down 8.6% to 105,527 units - American Honda reported September sales of 105,527 units, down 8.6% versus last year. "Our sales momentum has continued through the third quarter with strong demand for Honda and Acura SUVs, and growing sales of electrified models. Despite some supply issues due to the preparation for EV manufacturing and supply challenges related to the catastrophic Hurricane Helene in the Southeast, we continue to gain sales momentum based on a flexible strategy of offering fuel efficient petrol, hybrid-electric and battery-electric models to meet the needs of our customers," said Lance Woelfer, vice president of Auto Sales at American Honda Motor.

12:12 EDT U.S. Steel releases economic impact analysis on Nippon Steel deal - U.S. (X) released a new economic impact analysis today, conducted by Parker Strategy Group, that assesses how the proposed $1B investment committed by Nippon Steel Corporation (NPSCY) to modernize U. S. Steel's Mon Valley Works following the closing of the pending merger with U. S. Steel would generate a significant economic impact in Pennsylvania. According to the study, if just 80% of the $600 million construction project is spent in Pennsylvania, the Nippon Steel investment would generate a $952.9M incremental economic impact over a two-year timeframe. Among the findings, the study showed concentrated economic impact to Southwest Pennsylvania and increased impact if construction dollars are spent in Pennsylvania. "Not only will this deal secure U. S. Steel's Pennsylvania footprint - an economic boon benefiting communities and employees - the Nippon Steel investment in Mon Valley Works facilities would cause a positive ripple effect across the Pennsylvania economy," said President and CEO of U. S. Steel David B. Burritt. "While the economic impact is undeniable, what is most heartening is the consequential economic and generational impact this investment will have on the families and communities of the Mon Valley." The study predicts that when just 40% of the investment is spent in state it would create nearly 2,500 jobs and generate an almost half billion-dollar economic impact -- 2,432 jobs, $476.4M total impact -- over a two-year period.

12:00 EDT Dine Brands rises 13.7% - Dine Brands is up 13.7%, or $4.27 to $35.50.

12:00 EDT Site Centers rises 46.7% - Site Centers is up 46.7%, or $5.51 to $17.31.

12:00 EDT Zepp Health falls -11.0% - Zepp Health is down -11.0%, or -48c to $3.87.

11:51 EDT Subaru of America reports September sales up 0.1% to 56,414 vehicles - Subaru of America reported 56,414 vehicle sales for September, an increase of 0.1% compared with September 2023. SOA also reported year-to-date sales of 493,612 a 5.6% increase compared with the same period in 2023.

11:40 EDT Toyota Motor reports U.S. September sales down 20.3% to 162,595 vehicles - Toyota Motor North America reported U.S. September sales of 162,595 vehicles, down 20.3% on a volume basis and down 9.9% on a daily selling rate, or DSR, basis versus September 2023. September electrified vehicle sales consisting of hybrids, plug-in hybrids, pure electrics and fuel cells were 48.4% of total sales volume and totaled 78,683, up 22.4% on a volume basis and up 38.3% on a DSR basis. Reference Link

11:08 EDT General Motors reports Q3 U.S. deliveries down 2% y/y to 659,601 vehicles - General Motors said it and its dealers increased retail sales by 3% year over year and delivered 659,601 total vehicles, down 2%, in the U.S. in the third quarter of 2024. The company said it achieved another record quarter of EV sales with 32,195 total deliveries, up 60% year-over-year and up 46% compared to the second quarter of 2024. "GM's EV portfolio is growing faster than the market because we have an all-electric vehicle for just about everybody, no matter what they like to drive," said Rory Harvey, GM executive vice president and president of Global Markets.

11:03 EDT Ascensia launches Eversense 365 CGM system in the U.S. - Ascensia Diabetes Care is launching the Eversense 365 continuous glucose monitoring system to people with diabetes in the U.S. Developed by Senseonics Holdings, Eversense 365 is the only CGM that provides one year of accurate monitoring with minimal disruptions, enabling confident decisions, long-term peace of mind, and enhanced quality of life with just one CGM. The device was cleared for use last month by the U.S. Food and Drug Administration for people with type 1 and type 2 diabetes aged 18 years and older.

10:12 EDT Mazda North America reports September sales up 6.5% to 29,841 vehicles - Mazda North American Operations reported total September sales of 29,841 vehicles, an increase of 6.5% compared to September 2023. Year-to-date sales totaled 313,452 vehicles sold; an increase of 15% compared to the same time last year. With 23 selling days in September, compared to 26 the year prior, the company posted an increase of 20.3% on a Daily Selling Rate, or DSR, basis.

10:09 EDT BAE Systems' RAD510 software development unit available for order - BAE Systems' RAD510 software development unit is now available for order to the space community. The SDU enables initial software implementation and testing as customers prepare to convert from the RAD750 single-board computer to the next-generation RAD510 SBC. Currently in qualification, the RAD510 SBC offers three times the performance capability of its predecessor, supporting critical space missions.

10:05 EDT First National Corp. completes acquisition of Touchstone Bankshares - First National Corporation has completed the acquisition by merger of Touchstone Bankshares effective October 1, 2024. . Immediately following the Merger, Touchstone Bank, the wholly owned subsidiary of Touchstone Bankshares, Inc., was merged with and into First Bank. Pursuant to the previously announced terms of the Merger, each outstanding share of Touchstone Bankshares, Inc. common stock and preferred stock is entitled to receive 0.8122 shares of First National Corporation's common stock. Following the Merger, the former branches of Touchstone Bank assumed in the Merger will continue to operate in Virginia as Touchstone Bank, a division of First Bank, and, in North Carolina, as Touchstone Bank, a division of First Bank, Strasburg, Virginia, until the systems integration is completed in February 2025. With the addition of Touchstone, the Company would have had approximately $2.1 billion in assets, $1.5 billion in loans and $1.8 billion in deposits on a combined pro-forma basis as of August 30, 2024. The combined company will deliver banking services through 33 branch offices in Virginia and North Carolina and 3 loan production offices, in addition to its full complement of online banking services.

10:00 EDT Dine Brands rises 13.8% - Dine Brands is up 13.8%, or $4.33 to $35.55.

10:00 EDT United Natural Foods rises 22.9% - United Natural Foods is up 22.9%, or $3.85 to $20.67.

10:00 EDT Amentum falls -14.5% - Amentum is down -14.5%, or -$4.68 to $27.57.

09:56 EDT V2X awarded position on $11.9B JETS 2.0 contract - V2X announces its selection for the $11.9 billion Defense Logistics Agency J6 Enterprise Technology Services 2.0 contract, securing its place amongst a select group of providers. "In today's rapidly evolving digital landscape, vigilance is paramount. V2X is proud to support the Defense Logistics Agency by delivering critical cybersecurity and IT modernization services to uphold their mission," said Jeremy C. Wensinger, President and CEO of V2X. Under the JETS 2.0 contract, V2X will provide a range of advanced IT solutions, including cloud services and cybersecurity services to the DLA. This indefinite-delivery/indefinite-quantity contract spans an initial five-year base period, with the potential for an additional five-year option, supporting both U.S. and international Defense Department operations with essential IT services.

09:51 EDT Alpha Technology Group Ltd trading resumes

09:48 EDT ZIM Integrated falls -8.1% - ZIM Integrated is down -8.1%, or -$2.08 to $23.58.

09:47 EDT Site Centers falls -70.6% - Site Centers is down -70.6%, or -$42.72 to $17.78.

09:47 EDT United Natural Foods rises 14.2% - United Natural Foods is up 14.2%, or $2.39 to $19.21.

09:46 EDT Alpha Technology Group Ltd trading halted, volatility trading pause

09:40 EDT New Fortress Energy trading resumes

09:34 EDT RTX's Raytheon awarded $192M contract from U.S. Navy to develop NGJ-MBX - Raytheon has been awarded a $192M contract from the U.S. Navy to develop the Next Generation Jammer Mid-Band Expansion, an upgrade to the current Next Generation Jammer Mid-Band system. This modification will extend the frequency range of the NGJ-MB system to counter additional threats. MBX provides additional capabilities to improve operational effectiveness.

09:32 EDT NextTrip prepares Compass.tv for soft launch, signs content creators - NextTrip announced the launch of its owned and operated Compass.tv travel discovery channel and app. The platform initially features over a thousand hours of travel video content designed to seamlessly convert into commerce opportunities, allowing viewers to book vacations directly through the channel using the NextTrip Booking Engine. In partnership with Dooya Media Group, we intend to expand Compass.tv's offerings by collaborating with influencers who have millions of travel-focused followers, creating a unique and comprehensive travel hub. The Compass.tv launch features partnerships with the following influencers, studios and content creators: Paul "Barbs" Barbato is a travel educator and creator of viral geography channel, Geography Now. Global Child TV is an inspirational brand based around traveling with purpose where Augusto Valverde, host and founder, explores the world through amazing experiences as life lessons are shared with the help of celebrity friends. INSIGHT TV is a leading premium unscripted global channel operator, delivering high-quality, diverse travel programming that appeals to a wide range of passionate consumers. Compass.tv viewers can look forward to programming such as My Van Life and Epic Exploring, and upcoming series like Paradise Kitchen: Bali and Roads Unknown. Off the Fence is an Academy Award winning factual studio, owned by ZDF Studios that produces and distributes non-fiction programming. They offer Compass.tv a wide range of travel content such as The Travel Bug, Finding Little Italy, and Nature's Greatest Moments, designed to maximize revenue and reach.

09:28 EDT Lexaria Bioscience appoints Michael Shankman as CFO - Lexaria Bioscience announces the appointment of Michael Shankman, CPA, as CFO effective immediately. As a member of the executive leadership team, Mr. Shankman will lead the Company's financial operations. Shankman has previously worked with Lexaria and assisted with its financial reporting and 2023 audit as a designated contractor and as such is deeply familiar with the Company. From 2021 to 2024 Mr. Shankman provided outsourced CFO and Controller services for a national service provider, gaining extensive experience and familiarity with both public and private companies in a wide variety of industry fields.

09:27 EDT Zara launches Zara Streaming powered by Bambuser - Zara has officially launched Zara Streaming, a video shopping platform powered by Bambuser. The debut event, starring legendary supermodel Cindy Crawford and her daughter Kaia Gerber, offered an interactive experience where viewers could shop Zara's latest collection in real-time. Directed by acclaimed filmmaker David Lowery and styled by fashion icon Carlyne Cerf de Dudzeele, Zara Streaming blended high fashion with seamless shopping. Viewers were able to instantly purchase pieces as they watched the mother-daughter duo bring the collection to life, offering personal styling tips that made the experience more engaging and relatable. Now available on-demand on Zara's website, Zara Streaming extends beyond a one-time event, allowing customers to revisit the show and shop the collection at their convenience.

09:25 EDT South Bow launches as independent company - South Bow is launching as an independent company after completing its planned separation from TC Energy. South Bow's common shares will commence trading on the Toronto Stock Exchange on Oct. 2, and are expected to commence trading on the NYSE on or about Oct. 8 under the ticker symbol SOBO. South Bow is a liquids pipelines company that connects resilient Canadian crude oil supply to markets in the U.S. Midwest and Gulf Coast through its strategic corridor, contractual framework, and financial position. South Bow intends to declare its inaugural dividend on Nov. 7, 2024. The dividend is expected to be paid on Jan. 31, 2025 to shareholders of record on Dec. 31, 2024.

09:23 EDT Airgain Fleet 5G Vehicle Gateway obtainsT-Mobile AT&T carrier certification - Airgain (AIRG) has received certification for its next generation AirgainConnect Fleet 5G Vehicle Gateway from top mobile network operators including T-Mobile (TMUS) and AT&T (T) and industry bodies for use across North America. The second generation of AirgainConnect Fleet( also known as AC-Fleet was launched at the Consumer Electronics Show in Las Vegas, Nevada earlier this year. It combines a 5G New Radio modem, Wi-Fi 6 router, gigabit ethernet, GNSS/GPS and high-performance antennas into a robust and compact unit that can be mounted to the roof of any vehicle. AC-Fleet has received industry accreditation from the Federal Communications Commission FCC , PCS Type Certification Review Board , Industry Canada IC as well as certification for use on AT&T and T-Mobile's mobile networks...AC-Fleet is now available for purchase in black or white and is already under trial by multiple customers in the United States, Canada and Asia. It is easy to install with fewer cables, has a simple setup and configuration process using multi-carrier eSIM technology, and is low maintenance due to its streamlined software and remote cloud management.

09:22 EDT PacBio, A*STAR and Macrogen launch genomics lab in Singapore - PacBio, in collaboration with the Agency for Science, Technology, and Research, or A*STAR, and Macrogen, announced the opening of a joint laboratory at A*STAR Genome Institute of Singapore. This new facility will provide the local research community access to cutting-edge long-read sequencing technology. This initiative marks a milestone for the expanding application of HiFi long-read sequencing in precision medicine, population genomics, and health and disease biology in Southeast Asia. Two PacBio Revio systems will be installed at the lab. PacBio Revio systems are equipped with PacBio's proprietary HiFi sequencing technology. In addition to supporting the National Precision Medicine long-read sequencing needs, the new joint lab will serve as a resource for Singapore's research community.

09:21 EDT TC Energy announces cash tender offers for seven series of debt securities - TC Energy Corporation has commenced separate offers to purchase for cash any and all of the seven series of outstanding notes of the series, up to a maximum of US$1,750,000,000 aggregate Total Consideration. Subject to the Maximum Purchase Condition, the series of Notes that are purchased in the Offers will be based on the acceptance priority levels. If a given series of Notes is accepted for purchase pursuant to the Offers, all Notes of that series that are validly tendered will be accepted for purchase. No series of Notes will be subject to proration pursuant to the Offers. The Offers are made upon the terms and subject to the conditions set forth in the Offer to Purchase dated October 1, 2024 relating to the Notes and the notice of guaranteed delivery attached as Appendix A thereto. Capitalized terms used but not defined in this announcement have the meanings given to them in the Offer to Purchase.

09:19 EDT Bion Environmental provides update - Bion Environmental gave an update and announced a shareholder call with management set for October 9. Bion is finalizing testing and data runs at its Ammonia Recovery System demonstration facility at Fair Oaks, Indiana. Final economic optimization is being completed, the company is acquiring data for a third-party engineering report, and is are preparing for final design of the full commercial scale ARS for the Stovall-Bion JV. Bion anticipates completion of this phase in this quarter. The company has received funding from the loan group, although a formal agreement is expected by mid-next week. Bion is in the pre-development phase of the Stovall-Bion project, with a goal to begin construction by December 31.

09:19 EDT TeleVox taking Practice Edition offering to annual Leaders Conference - TeleVox is taking its Practice Edition offering to the Mile High City for the annual Leaders Conference hosted by the Medical Group Management Association. Launched in March, TeleVox Practice Edition offers a suite of services designed specifically to help physicians and their staff overcome common industry challenges, including inefficient scheduling processes, poor communication, low retention, and reputation management. Leaders Conference attendees can preview the AI-enhanced platform at TeleVox booth 1013.

09:16 EDT Check Point completes Cyberint acquisition - Check Point completed its acquisition of Cyberint Technologies, a provider of external risk management solutions. Cyberint's key capabilities are now included in the Infinity Platform and managed services.

09:15 EDT Sun Communities provides preliminary assessment of Hurricane Helene impact - Sun Communities did not incur any material building or structure damage as a result of Hurricane Helene. The company has access to all its properties, and assessments are still in the early stages. Clean-up and restoration efforts are underway at all affected communities and marinas. At this time, Sun does not expect Hurricane Helene to have a significant impact on operating results or financial condition.

09:15 EDT Apollo Global 'ahead or on track' for 2026 targets from last Investor Day - Targets include: greater than $9.00 ANI per share, 2.5x FRE, 1.75 SRE, $15B capital generation, $1T AUM, $150B+ origination, $500M ACS revenue. Comments taken from Apollo's Investor Day event.

09:14 EDT Color Star Technology regains compliance with Nasdaq minimum closing bid price - Color Star Technology received a formal notification from Nasdaq that the company has regained compliance with Nasdaq Listing Rule which requires the company's ordinary shares to maintain a minimum bid price of $1.00 per share. This bid price deficiency matter is now closed.

09:13 EDT Wiley expands advanced Journal Portfolio into life and health sciences - Wiley announced plans to further expand the prestigious Advanced Portfolio, a series of highly-regarded journals in materials science, physics, and engineering communities, into new areas of study in the life and health sciences...Wiley plans to launch six new Advanced titles in key health and life sciences fields, such as cell and molecular biology, oncology, neuroscience, and plant science by the end of 2026. In addition, the Advanced Portfolio is deepening its reach in the physical sciences, with a particular focus on chemistry and artificial intelligence A .

09:12 EDT ESGL executive director purchases company shares - ESGL Holdings announced that its Executive Director, Mr. Lawrence Beng Hui, Law, has recently acquired 1,126,000 ordinary shares of the Company. These transactions, consisting of privately negotiated block trades and open-market purchases, were executed at an approximate average price of US$1.88 per share. As a result of these acquisitions, Mr. Law's ownership stake in ESGL will increase from 1.3% to 4.1%.

09:12 EDT Talos Energy trading resumes

09:11 EDT SES Space & Defense awards Comtech deal for next-gen modems, no terms - Comtech announced SES Space & Defense recently awarded the Company an initial order for Comtech's market-leading software-defined SLM-5650B and other next-generation modems. Initial quantities under this new contract are expected to be delivered over the next year. ..Comtech's portfolio of U.S. sovereign defense technologies and services, including the Company's SLM-5650B and next-generation modems, align with the Space Force Commercial Space Strategy and deliver capabilities that will enhance Combined Joint All Domain Command and Control operations. Comtech's expansive portfolio of defense and security technologies is designed to continuously evolve over time to enable digitalized SATCOM infrastructures and integrate services across blended military and commercial networks to significantly enhance mission effectiveness in future all-domain operations.

09:10 EDT Guardion Health Sciences announces adoption of plan of dissolution, liquidation - Guardion Health Sciences has notified the Nasdaq Stock Market of its intent to delist its common stock, par value $0.001 per share from the Nasdaq Capital Market. Guardion expects to file a Form 25 with the Securities and Exchange Commission and Nasdaq relating to the delisting of the Common Stock on or about October 11, 2024 and to suspend trading of its Common Stock on the Nasdaq Capital Market prior to the opening of trading on October 14, 2024. Guardion expects that the official delisting of its Common Stock will be effective October 21, 2024. The Company also announced that it has appointed Mark Goldstone, a member of the Company's Board of Directors, to serve as the Company's Interim President and Interim CEO, effective as of October 18, 2024. Mr. Goldstone replaces Ms. Jan Hall as President and CEO, whose departure from the Company, effective on October 17, 2024, was previously announced. As previously disclosed, at a special meeting of stockholders held on May 31, 2024, the stockholders of Guardion approved the adoption of a Plan of Liquidation and Dissolution following the completion of the sale of the Company's Viactiv brand and business. As a result, in addition to delisting its Common Stock, Guardion intends to file its certificate of dissolution with the Delaware Secretary of State on or about October 22, 2024, which Guardion expects to be effective on October 22, 2024. Commencing on the Effective Date, Guardion will close its stock transfer books, after which record holders of shares of Common Stock will cease to have any rights in respect of such shares of Common Stock, except the right to receive distributions, if any, pursuant to and in accordance with the Plan and under the General Corporation Law of the State of Delaware, and will be prohibited from transferring record ownership of their shares of Common Stock, except by will, intestate succession, operation of law or upon dissolution of such record holder or its successors. Guardion expects to pay a liquidating dividend to its stockholders of record as of the close of business on the day preceding the Effective Date, in one or more distributions, in an amount that is anticipated to total approximately $3.25 per share of Common Stock. However, there can be no assurance as to the timing and amount of the distribution to stockholders. There are many factors that may affect the amounts available for distribution to holders of the Common Stock including, among other things, the amount of taxes, employee costs, expenses relating to the dissolution, unanticipated or contingent liabilities arising hereafter and the proceeds we may receive from the sale of other remaining assets, if any. If the Company has underestimated its existing obligations and liabilities or if unanticipated or contingent liabilities arise, the aggregate amount ultimately distributed to the holders of Common Stock could be less than that set forth above. Alternatively, in the event that the Company retains additional cash reserves after satisfactorily satisfying its liabilities, there may be an additional distribution at a future date. At September 30, 2024, Guardion had 1,349,956 shares of Common Stock issued and outstanding. After the Effective Date, Guardion will not engage in any business activities except to the extent necessary to preserve the value of its assets, wind up its business affairs and distribute its assets in accordance with the Plan. Under the DGCL, Guardion will be continued for the term of three years following the Effective Date, or for such longer period as the Delaware Court of Chancery directs, for the purposes of prosecuting and defending suits by or against it and of enabling it to gradually settle and close the business, to dispose of and convey its property, to discharge its liabilities and to distribute to shareholders any remaining assets. Guardion also intends to seek no-action relief from the SEC as soon as practicable in order to indefinitely suspend its reporting obligations under the Securities Exchange Act of 1934, as amended and to file a Form 15 with the SEC in connection therewith. The Form 15 will serve as notice of suspension of the Company's duty to file reports under Sections 13 and 15(d) of the Act.

09:10 EDT Corpay appoints Mike Jeffrey U.S. chief revenue officer - Corpay (CPAY) announced the appointment of Mike Jeffrey, a former Paychex (PAYX) senior sales executive, to the newly established role of USA chief revenue officer, or CRO. This new CRO role, reporting to the CEO, will be responsible for new bookings in Corpay's core U.S. market, including the Fleet, Payables, and Workforce Lodging businesses. The CRO will also direct Corpay's cross-sell initiatives. A significant proportion of Corpay's customers already purchase products from multiple Corpay divisions. This new role is designed to create a more unified, single view of the customer across all Corpay segments and capture further cross-sell opportunities where significant white space exists.

09:09 EDT Annaly Capital, Rocket Mortgage enter strategic subservicing relationship - Rocket Mortgage, a part of Rocket Companies (RKT), and Annaly Capital Management (NLY) announced the companies have entered into a subservicing agreement. Under the relationship, Rocket will handle all servicing and recapture activities for a portion of the mortgage servicing rights held by Annaly. "Rocket is committed to the entire homeownership experience from budgeting and credit building, to home search, financing and servicing. We truly believe in building relationships with our clients that last a lifetime - whether through new mortgages or servicing loans," said Bill Banfield, Chief Business Officer of Rocket Companies. "We are honored to be working with Annaly and look forward to providing their serviced clients the same exceptional experience that has made Rocket a perennial recipient of J.D. Power's servicing award."

09:08 EDT Amplitude names Wade Chambers chief engineering officer - Amplitude announced that Wade Chambers has joined the company as its first chief engineering officer. With more than 25 years of engineering leadership experience, Chambers will lead Amplitude's Engineering organization. In his new role, Chambers will continue to expand Amplitude's integrated platform, which includes Analytics, Session Replay, CDP, and Experiment. Chambers has served as an advisor to Amplitude since 2016.

09:07 EDT Bioventus divesting advanced rehabilitation business to Accelmed Partners - Bioventus has signed a definitive agreement to sell its Advanced Rehabilitation business of its subsidiary, Bioness, to Accelmed Partners, a private equity firm focused on acquiring and growing commercial-stage HealthTech companies. The transaction includes a total cash consideration of $45M, including $25M in cash at close and up to $20M in potential post-closing earn-out payments. At the time of closing, the company expects to net approximately $20M after fees and expenses, which will be used to repay existing debt. The divestiture of the Advanced Rehabilitation business reduces the company's annual revenue by approximately $50M and annual Adjusted EBITDA by approximately $6M. The transaction is expected to close in Q4.

09:06 EDT Western Uranium & Vanadium acquires property to advance milling strategy - Western Uranium & Vanadium announced that the Company has executed a binding Stock Purchase Agreement to purchase 100% of the shares of Pinon Ridge Corporation and thereby acquire an approximately 900 acre property located in Montrose County, Colorado. In connection with the Agreement, the former PRC shareholders will be paid approximately USD830,000 for their PRC equity and shareholder loan repayments. The acquisition is the second property package Western has acquired in addition to the Maverick Mineral Processing Plant site in Utah and is part of Western's plans for developing and licensing one or more uranium and vanadium processing facilities to process production from its resource properties in Colorado and Utah. Western is utilizing a multiple site approach in order to optimize transportation and processing costs; notably, the Utah Site is located approximately four miles from Western's San Rafael project, while the Colorado Site is about 25 miles from Western's flagship Sunday Mine Complex. Significant accretion is sought through mine to mill proximity and the corresponding reduction to transportation and related costs. Purchasing the PRC Site has additional benefits having been previously licensed for a uranium mill in terms of offering a unique opportunity to leverage historical licenses, data and resources. The preliminary engineering design, developed by Precision Systems Engineering, may be utilized at both the proposed Utah Site and the PRC Site. Additionally, the Sites are being designed to process mined material from third party miners. This next generation conventional mill design will include a kinetic separation circuit to separate the mineralized rock from the waste rock in a pre-milling process. The Company plans to evaluate alternate financing approaches to best optimize value to Western's shareholders; scenarios will be considered that involve third parties owning or co-owning the Sites.

09:06 EDT CF Bankshares board increases quarterly dividend 17% to 7c per share - CF Bankshares announced that the Board of Directors of the Company declared a $0.07 per share quarterly cash dividend on its common stock and a corresponding $7.00 per share quarterly cash dividend on its Series D preferred stock. This represents a 17% increase over its previous quarterly dividend. The dividend is payable on October 19, 2024 to shareholders of record as of the close of business on October 11, 2024. Timothy T. O'Dell, President and CEO, commented, "We are pleased to reward our shareholders with a 17% increase in our dividend, which enhances total shareholder returns. We appreciate your confidence and support!"

09:04 EDT Amgen partners with La La Anthony - Amgen has partnered with multi-talented actress, producer and entrepreneur La La Anthony to share her personal journey living with plaque psoriasis, and to inspire people to be open with their doctors about how the disease affects their daily lives. As one of the more than 6 million people in the United States living with plaque psoriasis, La La understands the frustrations of living with this disease. Symptoms can distract from everyday moments, big and small, even influencing clothing or makeup choices.

09:03 EDT PTC Therapeutics announces FDA acceptance for filing of NDA for sepiapterin - PTC Therapeutics announced the FDA has accepted for filing the New Drug Application, NDA, of sepiapterin for the treatment of pediatric and adult patients living with phenylketonuria. A Prescription Drug User Fee Act, PDUFA, target action date is expected to be provided in the Day 74 Letter. "The FDA filing acceptance for sepiapterin is a critical milestone toward bringing this potential important therapy to children and adults living with PKU in the United States," said Matthew B. Klein, M.D., Chief Executive Officer of PTC Therapeutics. "The clinical trial data, including the evidence of enabling diet liberalization, support that sepiapterin can provide significant benefit to PKU patients, helping to meet the persistent, significant unmet need in this community."

09:02 EDT 180 Degree Capital notes average discount of NAV per share to stock price - 180 Degree Capital noted that the average discount between its estimated daily net asset value per share and its daily closing stock price during September 2024 and year-to-date through the end of September 2024, were approximately 21% and 20%, respectively. This discount was approximately 24% on September 30, 2024. As previously disclosed in a press release on November 13, 2023, 180 Degree Capital's Board of Directors has set two measurement periods of January 1, 2024 to December 31, 2024, and January 1, 2025 to June 30, 2025, in which it will evaluate the average discount between TURN's estimated daily NAV and its closing stock price pursuant to a Discount Management Program. Should TURN's common stock trade at an average daily discount to NAV of more than 12% during either of these measurement periods, the Board will consider all available options at the end of each measurement period including, but not limited to, a significant expansion of 180 Degree Capital's current stock buyback program of up to $5 million, cash distributions reflecting a return of capital to shareholders, or a tender offer. We currently believe that any option and amount selected by the Board will be chosen carefully to not jeopardize the long-term potential of TURN to create value by requiring the monetization of a significant portion of TURN's portfolio at historically low stock prices.

08:57 EDT TC Energy completes spinoff of Liquids Pipelines business into South Bow - TC Energy Corporation has completed the spinoff of its Liquids Pipelines business into South Bow Corporation. As a standalone entity, TC Energy is positioned to achieve greater success by executing a tailored strategy to fully capture the incremental value of its unique opportunity set. Focused on long-term energy fundamentals and capital discipline, the Company will maintain its regulated, low-risk and utility-like portfolio. The TC Energy common shares will resume "regular way" trading on the TSX and the NYSE on Oct. 2, 2024, under the designation TRP. The South Bow common shares will commence "regular way" trading under the designation SOBO on the TSX on Oct. 2, 2024, but will not trade "regular way" on the NYSE until one trading day after the U.S. Securities and Exchange Commission declares South Bow's registration statement on Form 40-F effective. TC Energy currently expects that the South Bow common shares will commence "regular way" trading on the NYSE on or about Oct. 8, 2024

08:56 EDT Harmony Biosciences provides comprehensive pipeline update - Harmony Biosciences will be providing a comprehensive pipeline update at its Investor Day event today, showcasing new data from its orexin-2 receptor agonist, next-generation pitolisant programs, and long-term extension data from its pitolisant program in idiopathic hypersomnia. The company will also provide program updates from its strategic acquisitions in Fragile X syndrome, FXS, and rare epilepsies, which have strengthened its late-stage development pipeline. Key Highlights: Orexin-2 agonist program: New data show BP1.15205 is based on a novel chemical scaffold and has demonstrated greater potency compared to all publicly disclosed data on orexin-2 agonists, with the potential to be best-in-class. Pitolisant in Idiopathic Hypersomnia: New data show robust and sustained efficacy of pitolisant in patients with idiopathic hypersomnia in the Long-Term Extension study. Pitolisant-HD program: Preliminary data confirm safety up to five times the highest labeled dose of WAKIX, establishing the safety margins for the pitolisant-HD development program. Fragile X syndrome program: A prespecified ad hoc analysis from the Phase 2 CONNECT-FX in Fragile X syndrome study , Social Avoidance subscale; this and other learnings from this trial have informed the design and selection of the primary endpoint for the Phase 3 RECONNECT study, which is on track for topline data in mid-2025. EPX-100 development program: New safety and tolerability data on EPX-100, topline data in DS is expected in 2026, and a pivotal Phase 3 trial for LGS is on track to initiate later this year.

08:54 EDT Aytu BioPharma enters exclusive commercialization agreement with Lupin - Aytu BioPharma and Lupin Pharma Canada announced the signing of an exclusive collaboration, distribution and supply agreement for Aytu's Adzenys XR-ODT and Cotempla XR-ODT product lines in Canada. Lupin will seek local regulatory approvals and marketing authorizations for both Adzenys XR-ODT and Cotempla XR-ODT, which is expected to occur over the next 18 to 24 months.

08:52 EDT Talos Energy trading halted, news pending

08:51 EDT Heico acquires Marway Power Solutions, terms not disclosed - HEICO Corporation announced that its Electronic Technologies Group acquired 92.5% of Marway Power Solutions for cash at closing. The balance of the company's ownership will continue to be held by its executive management. Further financial terms were not disclosed. HEICO stated that it expects the acquisition to be accretive to earnings within the year following the acquisition. Founded in 1980, Marway is a leading designer and manufacturer of power distribution solutions for mission-critical systems deployed in defense, aerospace, communications, test & measurement, and industrial applications on land, air, and sea. Its primary products are power distribution units, power supplies, automatic transfer switches and related control panels. Based in Santa Ana, CA, Marway employs approximately 50 people at its facility there. Paul Patel, Marway's long-time President and CEO, will continue leading the company and Marway will continue operating from its existing engineering and manufacturing facility. HEICO also stated that it does not expect any material Team Member turnover to result from the acquisition.

08:48 EDT Kraken announces over 50 mine-like targets found with MINSAS during exercise - Kraken Robotics announces that their Miniature Interferometric Synthetic Aperture Sonar was evaluated by five NATO navies at the Portuguese Navy annual Robotic Experimentation and Prototyping with Maritime Unmanned Systems exercise, which took place in Sesimbra and Troia, Portugal. Five Kraken MINSAS modules were integrated onsite to American, Dutch, Swedish, Belgian, and Portuguese uncrewed underwater vehicles. These systems combined were able to locate more than 50 mine-like targets over the course of the exercise. Kraken's MINSAS was used for a wide range of tasks during the exercise including area search and reacquire/identify. Real-time beamforming and georeferencing facilitated the rapid recovery of acquired data from payloads, enabling immediate post-mission analysis of data when the UUVs returned to shore using SeeByte's SeeTrack C2 System. Kraken SAS was also used in a multi-national collaborative autonomy exercise to survey mine-like objects in a full 'Find-Fix-Finish' mission. SeeByte's SeeTrack and Neptune collaborative autonomy software, combined with the U.S. Navy's C2 and TAK, were used to plan and execute the multi-national exercise. Additionally, SeeTrack provided the tasking of a VideoRay Defender remotely operated vehicle to conduct an in-stride digital 'Finish'.

08:45 EDT Cemtrex 's Advanced Industrial Services subsidiary wins $4.5M contract - Cemtrex has received a $4.5M contract through its Advanced Industrial Services subsidiary. The contract award is for both Phase 1 and Phase 2 of the Department of General Services' Elizabethtown Training Academy project. Phase 1 of the project involves the complete renovation of the HVAC systems at the academy, while Phase 2 will focus on the renovation of the Boiler Plant and the Domestic/Fire Protection piping. The project is expected to be completed in the company's FY25.

08:44 EDT Evoke Pharma announces warrant proceeds, board expansion - Evoke Pharma received approximately $3.0 million in gross proceeds from the amendment and exercise of existing warrants. The approximately $3.0 million in gross proceeds will be used to support working capital and general corporate purposes, including advancing the commercial efforts for GIMOTI. Details of the exercised warrants can be found in the corresponding SEC filing. No new warrants were issued with these transactions which closed on September 30, 2024. As part of this transaction, Nantahala Capital Management, an existing investor and warrant holder, has been granted the right to nominate two members to the company's Board of Directors.

08:43 EDT TerrAscend closes on remaining $26M draw of $140M debt financing - TerrAscend announced that certain entities consolidated by the Company in Michigan have completed the second draw of $26 million in gross proceeds of the Company's senior secured term loan for total gross proceeds of $140 million from funds managed by FocusGrowth Asset Management, along with other members of a loan syndicate, which was previously announced on August 2, 2024. The proceeds from the second draw were used to pay down the Company's higher interest Michigan debt. The Loan included an initial draw of $114 million in gross proceeds, which was completed in August 2024, bringing the total gross proceeds under the Transaction to $140 million. The Loan carries an interest rate of 12.75%, matures in August 2028, contains no prepayment penalties and is guaranteed by the Company and TerrAscend USA, Inc. No warrants were issued as part of the Loan. The Loan is secured by the Consolidated Entities in Pennsylvania, California and Michigan, as well as certain entities in Maryland. Ventum Capital Markets acted as the exclusive financial advisor to the Company for the Transaction.

08:42 EDT BlackSky wins $6M contract expansion from defense sector customer - BlackSky Technology won an approximately $6M contract expansion from an international defense sector customer, bringing the total annual commitment to nearly $18M, for subscription-based Assured access to Gen-2, high-cadence, low-latency imagery services. "BlackSky is setting new standards for space-based intelligence operations as a trusted mission partner to the most demanding defense and intelligence customers in the world," said Brian O'Toole, BlackSky CEO. "We have established a new era of real-time monitoring where our current Gen-2 rapid-revisit capabilities add a level of reliable persistence and transparency over critical areas of interest. This contract renewal is a testament that our unique rapid-revisit capabilities are meeting market demand," said O'Toole.

08:40 EDT GPS Marine adopts Intelligent Bio Solutions' Fingerprint Drug Testing technology - Intelligent Bio Solutions announced the addition of GPS Marine, a leading provider of marine construction and logistics services, to its growing number of customer accounts.

08:39 EDT Expion360 selected by Scout Campers as provider of lithium battery solutions - Expion360 announced a new partnership with Scout Campers, a subsidiary of Adventurer Manufacturing. As part of this collaboration, Scout Campers will equip their campers with Expion360's lithium-ion batteries as a standard option. Starting with model year 2025 production, each camper built by Scout Campers will feature a single Group 27 132Ah VHC internally heated lithium battery from Expion360. Additionally, customers will have the option to upgrade the power capacity of their camper by adding a second Expion360 battery.

08:38 EDT Workhorse Group's W56 step van completes 1,000 mile drive - Workhorse Group announced the completion of a 1,000-mile journey in its W56 step van. Starting with a drive from the Workhorse Ranch in Union City, Indiana to the company's headquarters in Cincinnati, Ohio, the W56 then continued 940 miles to Orlando, Florida, covering a total of 1,028 miles. This real-world demonstration highlights the W56's performance, reliability and durability as it arrives at the FedEx Forward Service Provider Summit after the three-day journey from Cincinnati. The vehicle successfully navigated through various terrains and difficult weather conditions. Hurricane Helene brought strong winds and heavy rain during portions of the journey, and the W56 performed reliably, maintaining steady performance and durability. With a 150+ mile range and an average efficiency of 27 MPGe during this trip, supported by regenerative braking and fast charging at public Level 3 charging stations, the W56 showcased its ability to handle the demands of long-distance travel. The vehicle excelled in every situation, from traversing mountain passes to covering over 900 miles of long highway stretches, despite the limited regenerative assistance opportunities on highways.

08:37 EDT Hesai, SAIC Volkswagen sign new partnership on automotive lidar program - Hesai Technology (HSAI) announced the signing of a cooperation framework with SAIC Volkswagen, a Sino-German joint venture operated by SAIC Group and Volkswagen (VWAGY). The cooperation will establish a strong foundation for Hesai and SAIC Volkswagen to build a new ecosystem for the automotive industry, with Hesai's advanced lidar products and technology at the core.

08:36 EDT InterDigital signs new license agreements with TPV - InterDigital has signed new patent license agreements with TPV, a major manufacturer of a range of digital TVs under various brands. These agreements license TPV to InterDigital's extensive portfolio of HEVC patents as well as DTV patents licensed through InterDigital's joint licensing program with Sony.

08:36 EDT Paychex sees FY25 interest on funds held for clients $145M-$155M - The company said, "Our business outlook for the fiscal year ending May 31, 2025 ("fiscal 2025") incorporates current assumptions and market conditions. Changes in the macroeconomic environment could alter our guidance. With consideration of these impacts, we have updated our business outlook as follows: Interest on funds held for clients is now anticipated to be in the range of $145 million to $155 million. Other income, net is now anticipated to be in the range of $30 million to $35 million. Other aspects of our guidance for fiscal 2025 remain unchanged from what we provided previously."

08:35 EDT Users report problems at Sony's PlayStation Network, says Downdetector - Reference Link

08:35 EDT Sony's PlayStation Network says 'some services experiencing issues' - Sony's PlayStation Network said on its website that "some services are experiencing issues," and that players "might have difficulty" logging in, creating accounts, launching games or getting video content. Reference Link

08:33 EDT GD Culture Group enter partnership with Tuolan Network Technology - GD Culture Group and its subsidiary, AI Catalysis announced its partnership with Tuolan Network Technology, aimed at further enriching and expanding the Company's AI Creator Community. Designed as a hub to empower creators to produce innovative AI-generated content, the Company's AI Creator Community aims to increase the exposure of the company's brand and technology, encouraging more people to use the Company's technology and services. As part of this initiative, the Company has introduced an AI Video Contest to inspire creators to explore the potential of AI in video production. The Contest invites participants from around the globe to submit their most innovative AI-generated videos, short films, and advertising content. This initiative is set to push the boundaries of creativity and technology, offering participants a platform to demonstrate how AI can transform storytelling and digital media. Winners and their works will be showcased on the official AI Catalysis website. Prizes and special awards will be granted to the selected winners, with some winners having opportunities to participate in the Company's future projects. To amplify the reach and impact of the Contest, Tuolan will leverage its expertise in TikTok operations, promoting the Contest across its extensive social media channels and networks. This collaboration ensures that the Contest garners significant visibility and attracts a diverse range of talented creators. In addition to the Contest, AI Catalysis and Tuolan will offer a series of courses designed to help AI creators enhance their skills. These courses will cover key areas such as advanced AI video production techniques, strategies for engaging TikTok audiences, and best practices for leveraging AI tools in creative projects. Tuolan's extensive experience in AI video production and TikTok content creation will be instrumental in delivering these courses, providing creators with the skills and knowledge needed to excel in a rapidly evolving industry.

08:32 EDT GreenPower Motor receives follow-on order for 10 EV Star Passenger Vans - GreenPower Motor Company announced an order for 10 EV Star Passenger Vans to be delivered to Washington University in St. Louis for on-campus student transportation. "We are excited to receive this second order from Washington University," said Claus Tritt, GreenPower's Vice President of Medium-Duty and Commercial Sales. "The University has been providing student transportation on campus for more than two years now with five EV Star Passenger Vans. This second group of ten all-electric, purpose-built, zero-emission GreenPower vehicles will allow the college to provide additional safe, sustainable and healthy transportation for its students."

08:31 EDT LivePerson announces the launch fo LivePerson Community - LivePerson announced the launch of the LivePerson Community, a new customer-driven destination that facilitates connection and growth across its global customer base. The community helps brands gain the maximum value from LivePerson's industry-leading customer conversations platform and transform their contact centers into digital-first hubs for customer experience.

08:30 EDT ParaZero receives new order for counter-drone system - ParaZero has received a new purchase order for its Counter-Unmanned Aerial Systems solution from a global Tier 1 defense and intelligence OEM company. ParaZero's C-UAS solution offers a drone neutralization system providing protection for critical infrastructure, sensitive military operations, and public spaces while also ensuring minimal disruption while neutralizing aerial threats.

08:29 EDT American Rebel ships first orders to Dichello Distributors - American Rebel announced the shipment of the first order to Dichello Distributors from AREB's operating subsidiary, American Rebel Beverages. The multiple pallet order consisted of 12oz and 16oz cans from the recently completed production run in late August 2024 that became available for shipment the first week of September and delivery was completed and received by Dichello Distributors on approximately September 20. Dichello Distributors is the largest privately owned Anheuser-Busch distributorship in Connecticut.

08:26 EDT FlexShopper files patent infringement lawsuits against Upbound Group, Katapult - FlexShopper (FPAY) has initiated legal action to defend its intellectual property filing patent infringement lawsuits against Upbound Group (UPBD) and Katapult Holdings (KPLT) alleging unauthorized use of FlexShopper's patented technologies. The lawsuits revolve around five key patents, granted between 2018 and the present, which protect FlexShopper's computer-implemented lease-to-own technology. The lawsuits accuse Upbound Group and Katapult of multiple forms of infringement, including direct infringement, contributory infringement, and inducement of others to infringe. FlexShopper is seeking both injunctive relief to prevent further infringement and monetary damages. The patents in question cover FlexShopper's systems and methods for enabling retailers to partner with third-party lease-to-own providers.

08:25 EDT Brink's appoints Nader Antar as president, Brink's Global Services - The Brink's Company announced the appointment of Nader Antar as EVP and President, Brink's Global Services, effective October 1, 2024. Antar will join the executive leadership team and report to Mark Eubanks, president and CEO. Most recently, Nader served as President, Saur International, headquartered in France. Antar succeeds Dominik Bossart, who stepped down from his position as EVP and President, Latin America and Brink's Global Services as of September 30, 2024 and will remain in the organization as a senior consultant to ensure a smooth transition.

08:24 EDT Brera Holdings commences trading on Upstream - Brera Holdings announced that as of 10:00 AM EST this morning, its Class B Ordinary Shares began trading on Upstream, a MERJ Exchange market and global securities trading app, under the ticker symbol BREA. The dual listing on Upstream provides international investors worldwide with streamlined access to Brera Holdings PLC shares using just an app.

08:21 EDT Golden Matrix's Meridianbet expands sports wagering product suite - Golden Matrix Group announced a substantial expansion to the width of the product lineup of its subsidiary, Meridianbet. The expansion, powered by GMGI's proprietary software developed by its Meridianbet subsidiary, introduces approximately 170 new games with over 2,000 additional betting selections per each match. This strategic move is designed to broaden the Company's market appeal and increase user engagement, revenue streams and market share in respective jurisdictions. The new offering introduces five game groups for each match: Players, Special, Corners, Cards, and Time Games. These additions provide users with a more comprehensive and immersive betting experience, potentially leading to increased user engagement and higher betting volumes.The expanded Meridian Special is now available for major European and global soccer leagues worldwide, including English Premier League, Spanish La Liga, Italian Serie A, German Bundesliga, French Ligue 1, UEFA Champions League, UEFA Europa League, UEFA Europa Conference League, Brazilian Serie A, Greek Superleague, Cypriot First Division and Belgian First Division A.

08:20 EDT Lead Real Estate board approves special cash dividend of 2c per share - Lead Real Estate announced that, on June 18, 2024, the Company's Board of Directors approved a special cash dividend, payable on or about September 30, 2024 to all shareholders of record as of June 30, 2024, with an American depositary receipt record date of June 28, 2024. The dividend, of $0.02 per share, or a total of approximately $286,193, was approved at the Company's annual general meeting held in September 2024.

08:19 EDT Aligos Therapeutics appoints David Perry as VP, business development - Aligos Therapeutics announced the appointment of David Perry as Vice President of Business Development, effective immediately. Most recently, he served as Senior Director of Business Development at Sangamo Therapeutics.

08:17 EDT Barinthus Bio completes enrollment for hepatitis B, prostate cancer trials - Barinthus Biotherapeutics completed enrollment for two clinical trials: HBV003, a Phase 2b clinical trial of VTP-300 in adults with chronic hepatitis B; and PCA001, a Phase 1 clinical trial of VTP-850 in men with rising prostate-specific antigen after definitive local therapy for prostate cancer. Interim data update for HBV003 is anticipated in Q4. Data update for PCA001 is anticipated in H1 2025.

08:16 EDT Capital Bancorp, Integrated Financial Holdings complete merger - Capital Bancorp announced the completion of its previously announced merger with Integrated Financial Holdings. At the effective time of the merger, IFHI merged with and into Capital, with Capital continuing as the surviving corporation. The transaction is expected to create a best-in-class nationwide leader in government guaranteed lending across both U.S. Department of Agriculture and U.S. Small Business Administration lending. The transaction will also create opportunities to scale Windsor Advantage, one of the nation's largest SBA Lender Service Providers, which currently services approximately $2.5 billion in loans across SBA and USDA. Pursuant to the terms of the Merger Agreement, each holder of IFHI's common stock, par value $1.00 per share was converted into the right to receive 1.115 shares of common stock of Capital; and $5.36 in cash per share of IFHI Common Stock, in addition to cash in lieu of fractional shares. Each share of IFHI Common Stock subject to vesting, repurchase or other lapse restriction that was unvested or contingent and outstanding immediately prior to the effective time fully vested and was cancelled and converted automatically into the right to receive merger consideration in respect of each such share of IFHI Common Stock underlying such restricted stock award. In addition, each stock option granted by IFHI to purchase shares of IFHI Common Stock, whether vested or unvested, outstanding immediately prior to the effective time, was assumed by Capital and converted into an equivalent option to purchase Capital Common Stock, with the same terms and conditions as applied to the IFHI stock option. The pro forma organization will have approximately $3 billion in assets, robust pro forma capital ratios and strong pro forma capital generation, allowing it to participate in the substantial lending opportunities that exist within the fast-growing renewable energy industry. Pro forma, approximately 70% of Capital's net income will be from commercial banking with approximately 38% of Capital's loan portfolio consisting of C&I and owner-occupied commercial real estate loans. Approximately 20% of the pro forma revenue is generated from fee revenue, further diversifying Capital's revenue stream. In connection with completion of the Merger, Marc McConnell will join the Board of Directors of Capital Bancorp, Inc. and Capital Bank, N.A. Mr. McConnell has served as Chairman of the IFHI board of directors since August 2020 and as Chairman of West Town Bank's board of directors since June 2009. A. Riddick Skinner, EVP of Government Lending at IFHI will join Capital Bank as Head of Government Guaranteed Lending. Melissa Marsal, EVP and Chief Operating Officer of IFHI, will join Capital Bank as Head of Commercial Bank Operations. Mike Breckheimer will continue to lead Windsor.

08:15 EDT Allurion Technologies announces publication of Allurion Program meta-analysis - Allurion Technologies announced the publication of a systematic review and meta-analysis evaluating the effectiveness and safety of the Allurion Program. The analysis reviewed studies conducted between 2016 and 2024 and included data from 11 observational studies comprising a total of 2,107 patients. The results of the meta-analysis demonstrated a mean weight reduction of 12.5% and significant reduction in body mass index, or BMI, of 4.75 kg/m2 at four months. Importantly, the analysis also confirmed the safety of the Allurion Balloon, with a rate of serious adverse events reported of just 0.90%. The study's findings are further supported by the observed improvements in metabolic health parameters, particularly in HDL cholesterol, triglycerides, and glycemia, indicating the broad-reaching benefits of the Allurion Program beyond just weight reduction.

08:13 EDT Kiromic BioPharma gives follow-up results for 1st patient in Deltacel trial - Kiromic BioPharma reports good safety and favorable ongoing efficacy results from the 10-month follow-up visit of the first patient treated in its Deltacel-01 Phase 1 clinical trial. This trial is evaluating Deltacel or KB-GDT-01, the Company's allogeneic, off-the-shelf, Gamma Delta T-cell GDT therapy, in patients with stage 4 metastatic non-small cell lung cancer NSCLC who have failed to respond to standard therapies. "As this patient is the most advanced in our ongoing Deltacel-01 clinical trial, we are particularly encouraged by these latest follow-up results that continue to validate the potential of Deltacel as a safe and effective treatment for patients with later-stage cancers," said Pietro Bersani, Chief Executive Officer of Kiromic BioPharma. "We believe these findings underscore the promise of our allogeneic GDT therapy in providing durable clinical benefit." ...Continued meaningful results could represent a significant breakthrough for these late-stage cancer patients with limited treatment options."...Kiromic expects to report additional follow-up results from the fourth patient enrolled in this study in October.

08:13 EDT Nogin's Intelligent Commerce technology selected by Pooof! teeth whitener - Nogin announced that Pooof!, the dissolving teeth-whitening strips developed by cosmetic dentist Bill Dorfman, has selected Nogin's Intelligent Commerce technology and end-to-end services to launch its direct-to-consumer business. Nogin's collaboration with Pooof! will see the implementation of its advanced Intelligent Commerce technology to support Pooof!'s D2C strategy. Nogin will provide comprehensive management of Pooof!'s online store, including inventory management, creative services, and performance marketing. Additionally, Nogin will support Pooof!'s multichannel e-commerce expansion by managing sales through platforms like Amazon and other marketplaces.

08:12 EDT NextPlat completes merger, business combination with Progressive Care - NextPlat announced that following shareholder approvals, it has completed the proposed Merger Agreement and Plan of Reorganization pursuant to which Progressive Care, a controlled subsidiary of the Company, has become a wholly-owned subsidiary of the Company. As a result of the Merger and Business Combination, Progressive Care's common stock has ceased trading on the OTCQB exchange effective today.

08:10 EDT Mainz Biomed CEO issues statement on upcoming milestones - Mainz Biomed released a statement to shareholders highlighting its strategic plans for maximizing shareholder value, clinical developments, and its upcoming FDA trial anticipated for 2025, which aims to pave the way for entry into the U.S. market. Highlights of the statement by CEO Guido Baechler include: "Our groundbreaking clinical results with our mRNA-based next-generation CRC screening test and our strategic pathway to FDA trials, which we plan to start in 2025, demonstrate our commitment to expanding into the world's largest healthcare market. These efforts, combined with our growing international footprint, underscore why we believe Mainz Biomed is currently undervalued relative to its potential...Like all our shareholders, management and the Board of Directors are concerned and disappointed with the performance of our stock price. We commit to our shareholders that we will continue to strive to deliver what we have promised under difficult market conditions. We are strongly convinced that 2025 will be a transformative year, positioning Mainz Biomed for substantial growth in global markets, particularly through our innovative diagnostic solutions." mRNA-based next-generation CRC screening tests are redefining standards in early cancer detection. Mainz Biomed's flagship non-invasive test not only targets the early detection of colorectal cancer but also focuses on precancerous lesions, demonstrating clinical success in both U.S. and European trials. Presentations this year have highlighted sensitivities exceeding 90% for detecting colorectal cancer and over 80% for advanced adenomas. In early July the company submitted for FDA Breakthrough Device Designation for its next generation CRC screening test. Following feedback from the FDA, the company has decided to withdraw its BDD application to focus on extending its clinical research program. Mainz Biomed will expand its dataset to include a larger average-risk patient population with its pivotal ReconAAsense trial. The company plans to submit this comprehensive data in 2025 to FDA. Successful completion of the FDA trial will allow Mainz Biomed's next generation CRC screening test to be marketed to Americans at risk of colorectal cancer. Mainz Biomed is advancing a pipeline of diagnostic technologies aimed at detecting multiple cancers. Mainz has redeveloped and relaunched an expanded version of its first-generation CRC screening test currently commercialized in Germany and selected other countries in Europe.

08:10 EDT SolarBank 's first solar project under development - SolarBank announces that it is nearing completion of construction on a 1.4 MW DC rooftop solar project located in Calgary, Alberta for Fiera Real Estate Investments Limited. Contributing to Fiera Real Estate's commitment to its Net Zero Pathway where two of its funds have established targets of Net Zero Carbon by 2040as well as the further expansion of the SolarBank portfolio, the Project is expected to become operational in November 2024 as a small-scale generator in the Alberta Interconnected Electric System. With the support of Zathura Investments, SolarBank is providing full-service development and engineering, procurement and construction (EPC) services for the Project under an EPC agreement with Fiera Real Estate. Following the completion of this pilot project, the Company expects to complete additional projects for Fiera Real Estate in the future.

08:10 EDT BioVie receives notice of allowance for U.S. patent covering liquid terlipressin - BioVie has received a Notice of Allowance from the United States Patent and Trademark Office for patent application no. 17/611,478 entitled "Formulations of Terlipressin." This Notice of Allowance is expected to result in the issuance of a US patent once administrative processes are completed. The allowed claims cover a novel liquid formulation of terlipressin acetate that has stability at room temperature for two years and can be packaged in a pre-filled syringe. BioVie expects the resulting patent will be approved for listing in the Orange Book. The patent supports BioVie's liquid formulation of terlipressin for development of a more patient-centric ambulatory treatment regimen for patients with ascites and hepatic failure in the US. Patients with cirrhosis and ascites have large volumes of fluid accumulate in the abdomen due to liver and kidney dysfunction. Patients that progress to refractory ascites face a one-year survival rate of approximately 50%1. To date, there is no approved medical therapy specifically for refractory ascites. Management of these patients is based upon procedures such as large-volume paracentesis and TIPS, which only provide temporary relief, lack disease-modifying effects, and lead to frequent life-threatening complications.

08:08 EDT SU Group enters government sponsored market with milestone agreement - SU Group Holdings announced a milestone agreement to install a Smart Site Safety System at a major Hong Kong hospital. This represents the Company's entrance into a new emerging, high priority government mandated market that seeks to use artificial intelligence and Internet of Things technologies to create safer and more efficient working environments. Financial terms were not disclosed but the Company noted it expects this to have a positive impact on its full year sales growth.

08:08 EDT Altus Power announces structuring of tax equity transaction, partnership model - Altus Power announced the structuring of a tax equity transaction and partnership model with its existing partners. This transaction marks an evolution for Altus Power. The deal is notable given its innovative structure, which allocates a portion of the investment tax credits from recently completed solar projects to an existing partner through a traditional tax equity partnership, consistent with those which Altus has formed in the past. However, the new structure leverages the flexibility created in the Inflation Reduction Act to directly transfer a majority of the ITCs from the tax equity partnership to other partners of Altus Power with significant tax capacity.

08:07 EDT Alaska Air inaugurates service on five new routes - Alaska Airlines is kicking off five new nonstop routes. Beginning today, guests can travel between Las Vegas and both San Diego and Santa Rosa/Sonoma County, and between Los Angeles and both Pasco, Washington, and Reno. We're also resuming our nonstop service between Portland and Atlanta. "Travel demand continues to be strong, and we are excited to provide our guests with more options for their next business trip or autumn getaway," said Kirsten Amrine, vice president of revenue management and network planning at Alaska Airlines. "With the addition of these new nonstop routes, we also continue to strengthen our presence throughout the state of California and connect Pacific Northwest communities with our broader network."

08:06 EDT CVS Health's Aetna announces 2025 Medicare products - Aetna, a CVS Health company, announced its 2025 Medicare products. "For 2025, our continued focus is ensuring members have the peace of mind that comes with access to reliable, affordable health care when and where they need it," said Anand Shukla, president of Aetna Medicare. "Our plans are backed by our excellent customer service, deep experience and steadfast commitment to serving members at every stage of their health journey."

08:05 EDT Kiniksa partners with Henrik Lundqvist for Life DisRPted campaign - Kiniksa Pharmaceuticals International has teamed up with National Hockey League Hall-of-Famer, Henrik Lundqvist, to launch Life DisRPted, a national campaign focused on raising awareness of recurrent pericarditis, its impact on quality of life, and the critical importance of early diagnosis and treatment. Lundqvist was diagnosed with recurrent pericarditis in 2021, ultimately leading to his decision to retire from the NHL.

08:04 EDT Abacus Life appoints Robert Phillips as SVP, investor relations - Abacus Life announced the appointment of RobertPhillips as Senior Vice President, Investor Relations and Corporate Affairs, effective immediately. Reporting directly to Jay Jackson, Chairman and CEO of Abacus Life, Mr. Phillips will lead Abacus Life's investor relations strategy to strengthen engagement with the investment and capital markets communities. He will also play a key role in advancing strategic business initiatives, building relationships within these communities, and overseeing corporate affairs to support the Company's growth objectives. Prior to Abacus Life, Mr. Phillips was Senior Managing Director with Nasdaq, serving as primary liaison to executives and board members of public companies.

08:03 EDT Cheche Technology announces strategic partnership with Tokio Marine - Cheche Group announced that it has entered into a strategic partnership with The Tokio Marine & Nichido Fire Insurance Company, as Cheche continues to broaden its collaborations with insurance companies in China. "We are excited to announce our strategic partnership with TMNCH and look forward to developing customized products and services together," said Lei Zhang, Founder, CEO, and Chairman of Cheche. "Not only is our capacity for innovation vastly increased as we expand and strengthen our relationships with insurance companies and automobile manufacturers, but our leadership position as the intelligent insurance platform in China is underscored as well."

08:02 EDT Stryker completes acquisition of Vertos Medical - Stryker has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis. The addition of Vertos Medical's differentiated portfolio will strengthen Stryker's impact in interventional solutions to address chronic pain.

07:58 EDT Plug Power collaborates with Carreras Grupo Logistico - Plug Power is collaborating with Carreras Grupo Logistico to launch a complete green hydrogen ecosystem in Spain. The initiative will aim to establish, through a fuel cell technology advantages validation project, the first hydrogen-powered logistics site in Spain at Carreras Grupo Logistico's logistics center in Masquefa, Barcelona. Plug is working with Carreras to replace existing lead-acid battery-powered forklifts with hydrogen fuel cells to support decarbonization and efficiency improvements of Carreras Grupo Logistico's operations. The transition to green hydrogen will improve energy efficiency, productivity, and sustainability while reducing operational costs. The project at Masquefa will serve as a testing site to evaluate the improvements using Plug's technology over batteries. Insights gained from the project will be used to scale the hydrogen fuel cell technology across other sites in Spain and integrate it into Carreras Group's core logistics business that includes 46 warehouses.

07:46 EDT Arcos Dorados to exercise option to renew MFA with McDonald's - Arcos Dorados (ARCO) notified McDonald's (MCD) that it will exercise its option to renew its master franchise agreement, or MFA, with McDonald's. As previously disclosed, Arcos Dorados received a renewal notice from McDonald's, on August 1, to replace the parties' existing MFA with a new, 20-year MFA, to be effective as of January 1, 2025. On September 30, and in line with the current MFA's renewal procedures, Arcos Dorados provided notice to McDonald's of its intention to exercise its renewal option. The parties are now working to finalize the new MFA agreement. Upon signing, the new MFA agreement is expected to include a renewal option for a new, 20-year MFA, beginning January 1, 2045. Additionally, the new agreement is expected to include a royalty of Gross Sales of 6.0% for the first ten years, 6.25% for the subsequent five years and 6.5% for the final five years. Arcos Dorados and McDonald's share in the belief that the Company's 20 countries and territories present significant opportunities for growth. In line with this view, the company expects to open approximately 90 to 100 restaurants in 2025.

07:40 EDT Plus Therapeutics' Rhenium Obisbemeda shows safety, potential efficacy - Plus Therapeutics presented an update on the ongoing ReSPECT-GBM Phase 1/2 clinical trial evaluating the company's lead asset Rhenium Obisbemeda for the treatment of recurrent glioblastoma. The data highlights the continued favorable safety profile and encouraging efficacy results of Rhenium Obisbemeda in a patient population with historically poor prognosis. ReSPECT-GBM is a first-in-human, open-label, Phase 1/2 study investigating feasibility, dose escalation, and critical convection enhanced delivery parameters to determine the maximum tolerated dose, maximum feasible dose, safety, and potential efficacy of Rhenium (186Re) Obisbemeda in recurrent adult glioma. Rhenium (186Re) Obisbemeda continues to show a favorable safety profile in the 42 enrolled patients; one dose-limiting toxicity has been reported, which was observed in Cohort 8. In Phase 2, most adverse events were mild or moderate, and largely unrelated or unlikely related to the drug. To date, 88.9% of Phase 2 patients met key CED drug delivery parameters shown to correlate with overall survival, achieving a tumor absorbed dose greater than100 Gy and radiation coverage of greater than70%. In terms of objective tumor response based on quantitative image analysis, a statistically significant reduction in tumor volume rate change was seen in tumors receiving greater than 100 Gy absorbed dose. Sufficient tumor coverage correlated with tumor control, while regrowth occurred outside treated areas.

07:36 EDT Ollie's Bargain Outlet acquires former Big Lots stores - Ollie's Bargain Outlet was the winning bidder in a bankruptcy sale process to acquire seven former Big Lots store leases. The seven stores were part of a bankruptcy auction for the first wave of Big Lots store closures, which included 143 stores. Six of the seven stores have already completed the sale hearing process and received final approval from the Bankruptcy Court for the District of Delaware. The remaining one store is subject to final bankruptcy court approval and customary closing conditions. The company continue to plan to open 50 new stores, less two planned closures, in FY24.

07:35 EDT QuickLogic delivers eFPGA IP targeting TSMC N12e - QuickLogic announced the successful delivery of eFPGA IP for TSMC's N12e 12nm process to a large multi-national customer, achieving delivery in record time-within three months from finalizing specifications to IP completion. This follows the announcement in March of this year, when QuickLogic secured the contract and began working closely with the customer to define the bespoke eFPGA IP that meets their specific requirements.

07:34 EDT Abeona Therapeutics announces employment inducement grants - Abeona Therapeutics has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On September 30, 2024, the Compensation Committee of Abeona's Board of Directors granted restricted stock equity awards as a material inducement to employment to eight individuals hired by Abeona, which equity awards relate to, in the aggregate, up to 23,100 restricted shares of Abeona common stock. One-third of the shares subject to such restricted stock awards will vest yearly on each anniversary of the Grant Date, such that the shares subject to such restricted stock awards granted to each employee will be fully vested on the third anniversary of the Grant Date, in each case, subject to each employee's continued employment with Abeona on the applicable vesting dates.

07:33 EDT Mangoceuticals launches oral semaglutide for advanced weight loss treatment - Mangoceuticals' oral Semaglutide weight loss treatment marketed and branded under the name 'Slim,' is now available for purchase on the company's website. According to the New England Journal of Medicine, Semaglutide has become widely recognized for its effectiveness in aiding weight loss by regulating appetite and promoting a feeling of fullness. MangoRx's formulation is available as an oral dissolvable tablet and compounded with Vitamin B6. The company anticipates leveraging the increasing demand for GLP-1 peptides, including Semaglutide, to increase revenues in the coming quarters.

07:32 EDT RIV Capital appoints Vautrin as interim CEO - RIV Capital announced that Mike Totzke, Interim Chief Executive Officer and Chief Operating Officer, has resigned from the company, effective October 1st, 2024. The Board of Directors has appointed its current Chief Retail Officer, David E Vautrin, as Interim Chief Executive Officer. David E Vautrin is a highly experienced executive who has been in the cannabis industry for seven years and with RIV Capital since June 2024.

07:25 EDT Calian Group, Walmart Canada collaborate for specialty pharmacy offerings - Calian Group Ltd. (CLNFF) has agreed to collaborate with Walmart Canada (WMT) to expand the retailer's specialty pharmacy capabilities through licensing Calian's custom-built digital health platform, Nexi. Through Walmart Canada's network of 331 pharmacies nationwide, the retailer is able to dispense the vast majority of compounding and specialty pharmacy medications. However, through this new digital health platform, Walmart Canada will be able to better meet Canadians' healthcare needs by delivering an enhanced, seamless and secure experience to patients with chronic medical conditions and complex medication requirements. Nexi will provide Walmart Canada pharmacies with a simple, efficient, all-in-one smart pharmacy tool to automate the administration of their patients' specialty pharmaceutical needs, while also leveraging Calian's unique capabilities within health services, learning, cloud services and infrastructure security monitoring and protection.

07:23 EDT Climb Channel Solutions launches Bluebeam in LATAM territory - Climb Channel Solutions has announced the expansion of Bluebeam offerings into LATAM. Climb will offer in-region sales and technical assistance to Bluebeam partners within LATAM, in addition to their continued business in North America.

07:22 EDT Bitfarms provides September 2024 production and operations update - Bitfarms announced its monthly production report for September. On September 13, Bitfarms announced a hosting agreement with Stronghold Digital Mining that will accelerate the deployment of 10,000 Bitmain T21 miners which will bring an immediate anticipated increase of ~2.2 EH/s to Bitfarms' operational capacity when deployed. On September 23, Bitfarms entered into a settlement agreement with Riot Platforms in advance of the Special Meeting of Bitfarms Shareholders. The Special Meeting, originally scheduled to be held on November 6, has been rescheduled to November 20. Bitcoin difficulty increased 1.2% in the month. As a result, September mining operations generated 217 BTC compared to 233 BTC in August. September 2024 operating highlights include: 11.3 EH/s operational at September 30, 2024, up 85% Y/Y; 10.3 EH/s average operational, up 78% Y/Y and down 1% M/M; 21.1 BTC/average EH/s, down 6% from the previous month due to the increase in average network difficulty; 217 BTC earned, 7% lower M/M and 47% lower Y/Y; 7.2 BTC earned daily on average, equal to ~$461K per day based on a BTC price of $64K at September 30. Sold 173 of the 217 BTC earned for total proceeds of $10.5M. Total liquidity of $146M, including $73M in cash at September 30. Added 44 BTC, bringing Treasury to 1,147 BTC, up from 1,103 BTC last month and representing $73.4M based on a BTC price of $64K at September 30, 2024. The employment dispute with the former CEO has been settled.

07:19 EDT BioMarin, Camp4 enter strategic research collaboration - CAMP4 Therapeutics announced a new research collaboration with BioMarin Pharmaceutical Inc. aimed at advancing novel therapeutics that increase protein levels by targeting regulatory RNA sequences, which are key elements controlling gene expression. Under the terms of the agreement, BioMarin has the right to select two targets identified by CAMP4's RAP Platform to advance into clinical development.

07:16 EDT Iridium Certus selected by Brazilian railway operator MRS Logistica - Iridium Communications announced that Satcom Direct Brasil, a distributor of critical telecommunications services, and MRS Logistica S.A., a freight train operator, have implemented Iridium Certus satellite connectivity on MRS Logistica's railway network for the first time in Brazil. The Iridium Certus 700 service will be used to enable real-time communication between train drivers and operation centers, resulting in a faster and safer logistical process.

07:16 EDT Adeia enters into multi-year IP license renewal with Vizio - Adeia (ADEA) has renewed its intellectual property license agreement with Vizio (VZIO). Under the terms of the agreement, the multi-year license renewal extends Vizio's access to Adeia's media IP portfolio for its products and services.

07:15 EDT CytoSorbents sees Q3 product sales $8.3M-$8.5M vs. $7.8M last year - The company said, "We estimate that our Q3 2024 Product Sales will be in the range of approximately $8.3 million to $8.5 million, representing growth of 7% to 10%, versus $7.8 million in Q3 2023. A planned temporary slowdown in production to rebalance inventory levels coupled with a short-term manufacturing issue resulted in a significantly lower number of CytoSorb devices produced in the quarter. Because of this, we estimate that our product gross margins for Q3 2024 will be in the range of approximately 50% - 60%, compared to 71% in Q3 2023. The Company believes the short-term manufacturing issue has been resolved and expects a return to more normalized production levels and product gross margins in Q4 2024. The Company continues to have sufficient inventory to meet demand."

07:13 EDT Dominion completes sale of Public Service Company of NC to Enbridge - Dominion Energy (D) announced closure of the sale of its Gastonia, N.C.-based natural gas utility, Public Service Company of North Carolina, NC, to Enbridge Inc. (ENB) for approximately $3.2 billion, including assumed indebtedness and adjusted for customary closing items. This is the last of three separate transactions as part of an agreement the company and Enbridge announced on Sept. 5, 2023, whereby Dominion Energy would sell its Ohio-, Utah-, and North Carolina-based gas utilities for a total enterprise value, inclusive of assumed debt, of approximately $14 billion. Previous transactions closed in March and May.

07:12 EDT Zapata AI partners with MAG Aerospace for airborne surveillance platform - Zapata AI announced the first commercial agreement of its partnership with MAG Aerospace. MAG is an independent defense contractor providing full-spectrum outsourced ISR - intelligence, surveillance, reconnaissance - services for manned and unmanned systems, and a full spectrum of multi-domain deep sensing capabilities, including cyber, electronic warfare, and tactical communications in theaters around the world. In the initial phase of the partnership, Zapata will build foundational elements of MAG's next-generation integrated surveillance platform. The Zapata and MAG teams will work to enable next-generation ISR relying upon advanced sensor fusion technology, bringing together airborne and ground-based sources, and a variety of signal and sensor types powered by real-time data processing, correlation, image classification, and decisioning at the edge to automate target acquisition, identification, and tracking.

07:10 EDT Eyenovia commences manufacturing of second generation Optejet device - Eyenovia announced that the Company has commenced manufacturing of registration batches of its FDA-approved mydriasis product, Mydcombi, a key step in the approval process for its Gen-2 Optejet dispensing platform. Mydcombi will undergo 12-month stability testing and other functional testing in the Gen-2 Optejet device that is consistent with feedback from the Type-C meeting on Eyenovia's device qualification plan that the Company received from the FDA in July. Eyenovia anticipates completion of testing of its Mydcombi registration batches by the end of next year, with a potential SNDA filing in early 2026.

07:10 EDT Nouveau Monde announces payment of accrued interests - Nouveau Monde Graphite announces the payment of accrued interests as part of a previously announced private placement. Settlement of accrued interests:Upon the approval of the TSX Venture Exchange and the New York Stock Exchange the accrued interests owed to Investissement Quebec or the third quarter of 2024 under the unsecured convertible note, as amended and restated ssued in connection with the private placement announced by press release dated November 8, 2022 will be deemed paid. 205,460 common shares at a price of US$1.59 representing an aggregate amount of US$326,681 will be issued and share certificates will be delivered to the Holder at the maturity, conversion or redemption of the Note in payment of the accrued interests due on September 30 for the third quarter of the year. The issuance of Common Shares is subject to the approval of the Exchanges and, when issued, will be subject to a hold period of four months and one day.

07:09 EDT QuantaSing Group board approves special dividend of 6.7c per share - QuantaSing Group announced that its board of directors has approved the declaration and distribution of a special dividend of $0.067 per ordinary share. The aggregate amount of the Special Dividend will be approximately $11M, which is payable in U.S. dollars and in cash, and will be funded by surplus cash and to be paid out from the share premium account of the Company. The dividends are expected to be paid on or around November 7, 2024 to the holders of the Company's ordinary shares, and on or around November 15, 2024 to the holders of the ADSs, of record, as of the close of business on October 30, 2024. Dividend to be paid to the holders of ADSs issued by the depositary of the ADSs will be subject to the terms of the deposit agreement.

07:08 EDT Emcore confirms receipt of unsolicited, non-binding proposal from Mobix Labs - EMCORE Corporation (EMKR) confirmed that it has received an unsolicited, non-binding proposal from Mobix Labs, Inc. (MOBX) to acquire all of the Company's outstanding shares for $3.80 per share in cash. The Company's Board of Directors continues to evaluate a range of strategic and financial options to enhance shareholder value. The Company's Board of Directors and management team are committed to acting in the best interests of all shareholders. Consistent with its fiduciary duties and in consultation with the Company's financial and legal advisors, the Company's Board of Directors will carefully review Mobix's proposal to determine the course of action that it believes is in the best interest of the Company and its shareholders. The Company does not intend to make further comments regarding potential transactions or provide any public updates regarding proposed or potential transactions, unless required by applicable law or a regulatory body. There can be no assurance that any transaction will be completed at this price or at any other price with such third party or any other third party.

07:07 EDT Canadian Solar's e-STORAGE to deliver storage solutions to Huatacondo project - Canadian Solar announced that e-STORAGE, which is part of the Company's majority-owned subsidiary CSI Solar Co., has secured a turnkey EPC contract to supply a 98 MW/312 MWh DC Battery Energy Storage System, BESS, to the Huatacondo project in Chile. The project, developed by Sojitz Corporation and Shikoku Electric Power through their subsidiary AustrianSolar Chile Cuatro, is set to commence construction in the first quarter of 2025. e-STORAGE will provide and integrate its advanced SolBank 3.0 energy storage solution for the project. Under the EPC contract, e-STORAGE will manage all civil, mechanical, and electrical infrastructure for the project.

07:06 EDT EDAP TMS announces first patients treated in Phase I/II study of Focal One - EDAP TMS announced that the first patients have been treated in a Phase I/II study evaluating the Company's proprietary Focal One robotic high-intensity focused ultrasound technology for the treatment of benign prostatic hyperplasia. The Phase I/II study is a company-sponsored, prospective, multicenter clinical trial designed as a two-part study. Part 1 of the Phase I/II study will take place at two leading academic prostate treatment centers in France with a recognized expertise in the treatment of BPH as well as in the use of Focal One HIFU technology. Part 1 is designed to define the optimal treatment parameters to effectively treat BPH and its related symptoms with minimal side effects. Part 2 of the study will expand patient enrollment across a larger number of treatment centers in order to validate the safety and efficacy of the parameters as defined in Part 1 of the study.

07:05 EDT FDA gives Surmodics clearance for Pounce XL Thrombectomy System - Surmodics announced it has received U.S. Food and Drug Administration FDA 510(k) clearance for its Pounce XL Thrombectomy System..."Securing FDA clearance for the Pounce XL Thrombectomy System is a major step forward in Surmodics' pursuit of a complete mechanical thrombectomy solution for all peripheral arteries, notably critically ischemic lower extremity vessels," said Gary Maharaj, President and Chief Executive Officer of Surmodics. "The Pounce Thrombectomy Platform has already demonstrated its performance as a rapid, efficient solution for the removal of both acute and chronic thrombi and emboli in peripheral arteries without the use of thrombolytics..." Surmodics expects to initiate limited market release for the Pounce XL Thrombectomy System in the first half of 2025, with commercialization planned following the completion of the limited market release.

07:05 EDT Oryzon Genomics receives minutes from End-of-Phase II meeting with FDA - Oryzon Genomics announced the receipt of the official meeting minutes from a recent End-of-Phase II meeting for vafidemstat in Borderline Personality Disorder with the US Food and Drug Administration. Based on the feedback received, ORYZON will now move forward with preparing a full PORTICO-2 Phase III trial protocol to be submitted to the FDA for study approval. At the End-of-Phase II meeting with the FDA, held in late August, various aspects of vafidemstat's development plan were thoroughly evaluated and discussed. The minutes cover the FDA's opinion on the suitability of the vafidemstat program to date in several critical areas: preclinical data, toxicology, clinical pharmacology, and iv) clinical studies. The meeting minutes confirm that both the company and the FDA reached clarity on several key elements of the PORTICO-2 Phase III clinical trial design for vafidemstat. The most significant points are summarized as follows: Agitation-aggression in BPD has the potential to be acceptable as a target indication. The FDA agrees that Oryzon may pursue a Phase III study using STAXI-2 Trait anger as a primary efficacy endpoint measure, but the company will have to provide additional information to demonstrate that STAXI-2 Trait anger is a clinically meaningful endpoint in this indication. Secondary endpoints will include both patient-rated and clinician-rated scales, as CGI-S A/A to assess agitation/aggression, and BEST and CGI-S to assess overall BPD improvement. A Qualitative Research Study will be conducted with a subset of PORTICO-2 patients to provide further validation of the proposed endpoints. The Qualitative Study protocol will be submitted prior to its initiation for FDA review and feedback. Oryzon plans to also provide the psychometric properties and performance for the selected primary and key secondary endpoints for FDA review prior to the initiation of the Phase III study. The estimated total sample size for the PORTICO-2 Phase III study is 350 patients, with a trial duration of 18 weeks in total. Subject to FDA review of the final data, the PORTICO-2 Phase III study has the potential to be one of the two registrational trials required by the FDA. Using the same scale selected now as primary endpoint for assessing agitation-aggression in BPD in the PORTICO-2 Phase III trial, the STAXI-2 Trait anger scale, the Phase IIb PORTICO study demonstrated a nominally significant and clinically meaningful reduction of agitation and aggression in the vafidemstat group as compared to placebo. Based on the positive feedback from the FDA, Oryzon will now start preparations for the Phase III program, including the preparation of a full protocol for PORTICO-2 Phase III trial to submit to the FDA. The company will now also engage with European regulatory agencies following standard practice before initiation of the PORTICO-2 Phase III trial.

07:03 EDT Colliers International extends agreement with Global Chairman & CEO - Colliers International has extended the term of the existing management services agreement with its Global Chairman and CEO and largest shareholder, Jay Hennick, to January 1, 2029. The agreement was due to expire in April 2026. In connection with this extension, Colliers has created a new performance-based long term incentive plan that ties a significant proportion of Hennick's total compensation to the achievement of certain market capitalization-based growth targets. Under this arrangement, Hennick has been granted a total of 428,174 cash-settled performance units that are subject to the satisfaction of certain performance-based vesting conditions during the period ending January 1, 2029. To the extent incentives are earned, Colliers will be obligated to make a one-time cash payment equal to the number of vested units multiplied by the twenty-day volume-weighted average trading price of the Colliers subordinate voting shares at such time. For the full amount of the units to vest, Colliers' market capitalization would have to increase to approximately $12.3B, double Colliers' market capitalization as at December 31, 2023. A smaller portion of the performance units may vest and be paid if certain lower market capitalization hurdles are satisfied during the term. The performance units cannot be share settled and do not give Hennick any rights as a shareholder of Colliers.

07:00 EDT Genesco appoints Sandra Harris as CFO - Genesco announced the appointment of Cassandra "Sandra" Harris as Senior Vice President, Finance and CFO effective October 7, 2024. Harris succeeds Thomas A. George, whose planned retirement will take effect on December 12, 2024 to ensure an orderly transition. Harris joins Genesco with an impressive background of CFO and finance leadership roles in retail and consumer brands companies, including at VF Corporation. Harris will report directly to Vaughn and will oversee Genescos accounting, financial planning and analysis, investor relations, treasury, procurement and tax functions. During the transitional period, George will continue as Genescos Principal Accounting Officer.

06:58 EDT Tenet Healthcare completes sale of five hospitals in Birmingham - Tenet Healthcare Corporation has completed the sale of its 70% majority ownership interest in Brookwood Baptist Health in Birmingham to Orlando Health consistent with previously disclosed terms. The completed transaction includes five hospitals - Brookwood Baptist Medical Center, Citizens Baptist Medical Center, Princeton Baptist Medical Center, Shelby Baptist Medical Center, Walker Baptist Medical Center - and other related operations. Tenet's Conifer Health Solutions subsidiary has entered into a ten-year contract to provide comprehensive revenue cycle management services for these operations.

06:41 EDT Bionomics intends to re-domicile to the U.S. - Bionomics announced its intention to re-domicile from Australia to the U.S. via a proposed scheme of arrangement between Bionomics and its shareholders that will be governed by Australian law. Implementation of the Scheme is subject to approval of Bionomics' shareholders as well as regulatory and court approvals. Bionomics is an Australian corporation and its ordinary shares, in the form of ADSs, have been trading in the U.S. on Nasdaq since December 2021. Each ADS represents 180 ordinary shares of Bionomics. Should the Scheme be approved by Bionomics shareholders and an Australian court, all shareholders of Bionomics will receive a proportionate number of shares of common stock in Neuphoria Therapeutics, a new parent company that was incorporated in the U.S. State of Delaware for purposes of the re-domiciliation. Effective July 1, Bionomics no longer qualified as a foreign private issuer and, for this and other reasons, Bionomics' board has approved a plan to re-domicile Bionomics from Australia to Delaware. A re-domiciliation would eliminate significant Australian compliance costs, including avoiding the need to prepare financial statements in accordance with International Financial Reporting Standards as well as U.S. generally accepted accounting principles. Following the implementation of the Scheme, Neuphoria will become the ultimate parent company of the Bionomics group of companies, with Bionomics becoming a wholly-owned subsidiary of Neuphoria. Holders of fully paid ordinary shares in Bionomics will be entitled to receive one share of common stock in Neuphoria for every 1,440 Bionomics Shares held on the Scheme record date; and holders of Bionomics ADSs will be entitled to receive one Neuphoria Share for every 8 ADSs held in Bionomics on the Scheme record date. Holders of Bionomics options and warrants will be asked to exchange those securities for equivalent options and warrants in Neuphoria based on the same exchange ratio as the Scheme ratio. The re-domiciliation is not expected to result in any material change to Bionomics' assets, management, operations or strategy, and is expected to be structured on a tax-neutral basis to Bionomics and its shareholders. The Board has appointed an independent expert to assess if the Scheme is in the best interests of holders of Bionomics Shares. The Board unanimously recommends that Bionomics shareholders vote in favour of the Scheme. Bionomics shareholders do not need to take any action at this time. Bionomics shareholders will be given the opportunity to vote on the Scheme at the Scheme meeting expected to be held in late November and, subject to the conditions of the Scheme being satisfied, the Scheme is expected to be implemented in early December.

06:39 EDT Hut 8 announces early payoff of outstanding loan - Hut 8 announced the conversion of the entire ~$38 million outstanding balance of its subsidiary's outstanding loan with Anchorage Lending CA, LLC, a subsidiary of Anchor Labs, Inc. d/b/a Anchorage Digital, into common stock of the Company. Anchorage Digital has converted the ~$38 million outstanding balance of the loan at a price of $16.395 per share of common stock of Hut 8 pursuant to a Debt Repayment Agreement. . The share price represents a 51% premium to the 20-Day VWAP through September 26, 2024, the day prior to the signing of the Debt Repayment Agreement. Upon completion of the Conversion, the outstanding loan and all other related obligations of the Company and its subsidiaries have been satisfied.

06:36 EDT Shattuck Labs provides pipeline and financial update - Shattuck Labs announced a strategic pipeline prioritization to include the discontinuation of its clinical program, SL-172154. The company will turn its focus to SL-325, its DR3 antagonist antibody, and plans initial clinical development in patients with IBD, where TL1A/DR3 blocking antibodies have demonstrated compelling monotherapy efficacy. Shattuck to discontinue SL-172154 program and pivot to pipeline compound: approval of SL-172154 in TP53m AML and HR-MDS would require meaningful improvement in OS in large-scale, randomized studies. The company saw only modest improvements in OS in its Phase 1 trial and historically some erosion in efficacy would be expected in larger, randomized trials. Given Shattuck's current resources, the lack of a definitive OS benefit to date, and that no CD47 inhibitor has shown a significant efficacy signal in any indication to date, the company has chosen to reallocate its resources to drive SL-325 through Phase 1 clinical development. Shattuck and Ono Pharmaceutical mutually agreed to terminate their license agreement collaborating on preclinical development of certain compounds. Shattuck's lead candidate, SL-325, is a potentially first-in-class DR3 antagonist antibody for the treatment of IBD and other inflammatory autoimmune diseases. Shattuck expects to file an IND for SL-325 in 3Q25. As of June 30, cash and cash equivalents and investments were $105.3M. Shattuck has implemented a restructuring plan to prioritize the development of the company's DR3 program following the discontinuation of SL-172154. Approximately 40% of Shattuck's workforce will be impacted by the changes. The company expects to complete the reduction in force in Q4. The company believes its cash and cash equivalents and investments will be sufficient to fund its planned operations into 2027, beyond results from its planned Phase 1 clinical trial of SL-325.

06:34 EDT Stevanato to introduce Vertiva 10mL on-body delivery system platform - Stevanato Group announced the expansion of its Vertiva platform, which will include a 10mL option to be presented at CPHI Milan in October. The Vertiva easy-to-use platform can be pre-programmed to accommodate different motor driven dosing profiles, from micro-precision basal delivery to full-content bolus injections. This flexibility makes the platform ideal for administering a wide range of small molecule and biologic therapies, enabling treatment for conditions such as cardiovascular and metabolic disorders, oncology, immunology, and pain management.

06:27 EDT Moderna, Cenra Healthcare enter joint agreement to promote portfolio in Taiwan - Moderna and Cenra Healthcare, the sales and marketing arm of Cenra, announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Taiwan, including Moderna's COVID-19 vaccine, Spikevax. Under the agreement, Moderna will manufacture and distribute its mRNA respiratory vaccines. Cenra Healthcare will engage in promotion and execute medical education activities to ensure broad access to Moderna's mRNA respiratory portfolio across Taiwan. The agreement has an initial term until July 31, 2027, and no further details on the financial terms of the deal are being disclosed.

06:19 EDT Macau reports September casino revenue up 15.5% to 17.25B patacas - Macau's gaming bureau reported September gross revenue from games of fortune in the region was up 15.5% year-over-year to 17.253B patacas. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Resorts (MLCO). Reference Link

06:12 EDT BioNTech highlights AI capabilities, R&D use cases at AI Day - BioNTech presents an overview of its AI approach during an edition of the Company's Innovation Series, AI Day. "At BioNTech, we are at the forefront of integrating advanced AI to revolutionize individualized medicine. With our in-house AI specialist, InstaDeep, we are pioneering the use of artificial intelligence to develop personalized vaccines and targeted therapies," said Prof. Ugur Sahin, M.D., CEO and Co-Founder of BioNTech. "By introducing state-of-the-art technologies such as our BFN generative protein model and incorporating AI capabilities across our immunotherapy pipeline, we are unlocking the full potential of AI to deliver innovative vaccines and cancer treatments to patients worldwide". As part of the event, BioNTech will showcase the Company's approach to AI capability scaling and deployment across BioNTech's pipeline. These updates will cover the introduction of a new near exascale supercomputer, the launch of a novel BFN generative model, and multiple updates on the deployment of AI across BioNTech's immunotherapy pipeline.

06:11 EDT Modine Manufacturing appoints Telos CFO Mark Bendza to board - Modine (MOD) announced that Mark Bendza will join the company's board of directors effective immediately. Bendza currently serves as CFO at Telos (TLS).

06:09 EDT CEL-SCI selects Ergomed as CRO for Multikine registration trial - CEL-SCI announced its renewed collaboration with Ergomed Clinical Research for its upcoming FDA confirmatory Registration Study of Multikine in head and neck cancer. Ergomed will provide global comprehensive clinical operations support to ensure the timely and efficient execution of the trial. This partnership builds on their previous collaboration for the Phase 3 trial of Multikine, which was the largest study ever conducted in head and neck cancer. CEL-SCI achieved other major milestones including receiving pediatric waivers from the UK's Medicines & Healthcare Products Regulatory Agency and the European Medicines Agency. Multikine has already demonstrated promising results in its prior studies, showing a significant improvement in survival rates. In the target population for the confirmatory study, patients treated with Multikine had a 5-year survival of 73% vs 45% survival in the control patients, with a hazard ratio of 0.35. The confirmatory study is designed to provide the final data required for regulatory approval.

06:07 EDT Calibre Mining appoints David Schummer as SVP, COO - Calibre Mining announced the appointment of David Schummer as SVP & COO effective October 1, 2024, and Stephen McCaughey as Vice President Technical Services, Nicaragua. Prior to joining Calibre as COO, David was the COO for Perseus Mining, and prior to that he was the President of Ma'aden Gold & Base Metals. Stephen is a registered Member of the Australian Institute of Geoscientists and has over 30 years of experience in the mining industry including 14 years with BHP.

06:04 EDT Li Auto delivers 53,709 vehicles in September, 152,831 vehicles in Q3 - Li Auto announced that it delivered 53,709 vehicles in September, up 48.9% year over year. This brought the company's third-quarter deliveries to 152,831, increasing by 45.4% year over year. As of September 30, 2024, Li Auto had delivered a total of 341,812 vehicles in 2024, with cumulative deliveries reaching 975,176.

06:02 EDT Zeekr delivers 21,333 vehicles in September - Zeekr announced its delivery results for September. Zeekr delivered 21,333 vehicles in September, a 77% year-over-year increase. Year-to-date, Zeekr has delivered 142,873 vehicles in 2024, representing 81% growth over the same period last year. As of the end of September 2024, Zeekr's cumulative deliveries reached 339,506. On September 20, Zeekr officially unveiled its premium electric five-seater SUV, the Zeekr 7X, with deliveries commencing the very next day.

06:00 EDT Sony Pictures Entertainment CEO Vinciquerra to step down, Ahuja to succeed - Sony Group Corporation and Sony Pictures Entertainment, SPE, announced that SPE Chairman and CEO Tony Vinciquerra will step down from his role as SPE CEO, and that Ravi Ahuja, SPE's current Chairman of Global Television Studios and President and COO, will assume leadership of SPE as President and CEO, effective January 2, 2025. Vinciquerra will remain in an advisory role for SPE as non-executive Chairman until the end of December 2025. Ahuja will report to Sony Group Corporation Chairman and CEO Kenichiro Yoshida and Sony Group Corporation President, COO and CFO Hiroki Totoki. Vinciquerra joined SPE in June 2017, and has led the company's dramatic turnaround with five consecutive years. Ravi Ahuja joined SPE in 2021 to oversee all production businesses for Sony Pictures Television and the studio's India business as Chairman of Global Television Studios.

05:53 EDT ADNOC offers to acquire Covestro for EUR 62 per share - Covestro AG signed an Investment Agreement with certain entities of the ADNOC Group, including ADNOC International Limited and its subsidiary, ADNOC International Germany Holding AG. The agreement stipulates, among other items, that the Bidder will make a public takeover offer for all outstanding shares of Covestro at a price of EUR 62.00 per share. In addition, ADNOC International is committing itself to fully supporting the company's "Sustainable Future" strategy. At the same time, the Board of Management and the Supervisory Board of Covestro decided today that upon completion of the transaction, the company's share capital shall be increased by 10% and that, at and subject to closing, the new shares shall be issued to the Bidder against payment of a price per share equal to the offer price, thus, based on an offer price of EUR 62.00 against a total amount of EUR 1.17 billion, under simplified exclusion of subscription rights. Dr. Markus Steilemann, CEO of Covestro, said: "We are convinced that the agreement reached today with ADNOC International is in the best interest of Covestro, our employees, our shareholders, and all other stakeholders." The offer will be subject to a minimum acceptance level of 50 percent plus one share and customary closing conditions, including merger control, foreign investment control, EU foreign subsidies clearances. In connection with the conclusion of the Investment Agreement, the Board of Management, with the support of the Supervisory Board, has also decided to not propose a dividend payment until the transaction has been completed or until the expiration of the period for regulatory approvals or a termination of the Investment Agreement. Goldman Sachs and Perella Weinberg are acting as financial advisors to Covestro's Board of Management on the transaction, with Linklaters acting as legal advisor. For Covestro's Supervisory Board, Rothschild & Co and Macquarie Capital are acting as financial advisors, and SZA Schilling, Zutt & Anschutz as legal advisors.

05:45 EDT Caledonia Mining to sell share capital of Zimbabwe subsidiary for $22.35M - Caledonia Mining announced that it has signed a conditional sale agreement for the entire issued share capital of its Zimbabwe subsidiary, Caledonia Mining Services, which owns and operates the 12.2MWac solar plant that supplies power to Blanket Mine. CMS is to be sold to CrossBoundary Energy Holdings for $22.35M, payable in cash, and the power generation of the solar plant will continue to be sold to Blanket Mine by way of a power purchase agreement. The construction of the solar plant was initially financed by a registered offering of Caledonia's shares in the US in 2020 and this raised $13M through the issue of 597,963 shares. Since commissioning in February 2023, the solar plant has generated over 47,350Mwh of power, and profits attributable to the solar plant for the year ended December 31, 2023 were $728,023. The power generated from the solar plant has significantly reduced the use of diesel generators and grid power at Blanket Mine, ensuring approximately a fifth of the mine's daily electricity needs are met by solar power. The plant will continue to supply Blanket Mine under an exclusive power purchase agreement. The sales consideration will be reinvested in Caledonia's other projects that are expected to yield a higher return to our shareholders and will have the added benefit of focusing management's attention on its core business of gold mining and exploration. CBE was launched by the CrossBoundary Group, a mission-driven investment firm, in 2015 as Sub-Saharan Africa's first provider of fully financed commercial-industrial solar solutions.

05:37 EDT Nextracker inaugurates India's first Center for Solar Excellence - Nextracker inaugurated India's first Center for Solar Excellence, or CFSE, in Hyderabad, India. Spanning across 13 acres this facility will serve to advance solar tracker technology, further accelerating the region's energy transition. The CFSE will feature a 30,000 square foot lab, a solar tracker installation, and training facilities encompassing the entire project lifecycle-from structural, mechanical, and electrical design to construction, operation, and maintenance. Working closely with supply chain partners, customers, and third-party laboratories, Nextracker's cross-functional team of experts will be developing, testing, and commercializing proprietary technologies.

05:30 EDT Hafnia completes redomiciliation to Singapore - Reference is made to the stock exchange announcement made by Hafnia on September 20 regarding the subsequent court hearing at which the Supreme Court of Bermuda sanctioned the scheme of arrangement between the company and its shareholders pursuant to Section 99 of the Bermuda Companies Act 1981 as amended in order to effect a discontinuance of the company from Bermuda and continuance to Singapore and adopt the constitution of the company which will take effect upon continuance in Singapore. The court order has been filed with the Registrar of Companies in Bermuda and the company has obtained the final approval by the Singapore Accounting and Corporate Regulatory Authority.

05:20 EDT RWS Holdings names Jacqui Taylor chief people officer - RWS announced that Jacqui Taylor has joined its executive team as chief people officer. Taylor, who joined RWS in 2023 as VP of Human Resources, is responsible for the group's overall human resources strategy, including global talent acquisition, leadership development, colleague engagement and diversity, equity, inclusion and belonging. She brings more than 25 years' experience across several industries including the electronics, construction and testing, inspection and certification sectors. Before joining RWS she was group chief human resources officer at EDM Group.